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The need to administer more potent antimicrobial drugs is supported by the ever-
increasing incidence of multidrug resistance. Given the (necessary) higher toxicity of 
these drugs, administration into host circulation comes at a high risk to the patient. 
Drug delivery systems that are capable of more localized drug deposition, could limit 
host exposure. Here we propose the use of an autologous delivery system to shuttle 
drugs through circulation to protect the host from premature drug exposure. Our 
approach encompassed a multidisciplinary method to include physiology and 
microbiology. From the physiology side, macrophages exhibit great capacity to 
transverse endothelial barriers during the inflammatory process. From the 
microbiology side, micro-organisms have evolved to evade the immune system by 
harboring within these macrophages to later induce their own expulsion for 
dissemination. The work presented here describes how we have utilized the pore 
forming and actin polymerising ability of the Listeria monocytogenes effectors, 
listeriolysin-O and actin assembly-inducing protein, to produce a novel drug delivery 
system: the synthetic microbe. Firstly, we synthesised these effectors by using a GFP-
linked heterologous expression and purification system, with which we were able to 
produce effectors at a greater yield than previously reported. In vitro experiments 
further confirmed appropriate activity of synthesised proteins and finally, coating of 
these effector proteins onto polystyrene beads induced their expulsion from carrier 
macrophages. Furthermore, drug cargo expulsion did not result in lysis of the carrier 
cells, suggesting that macrophages could contribute to resolution of damage at target 
areas once cargo is released. In our opinion, this multidisciplinary approach may hold 
the solution to effective, controlled drug delivery. 
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Die noodsaaklikheid om kragtiger antimikrobiese middels toe te dien, word 
beklemtoon deur die toenemende voorkoms van veelvuldige middel weerstandigheid. 
Gegewe die (noodsaaklike) hoër toksisiteit van hierdie medisyne, hou die sistemiese 
toediening daarvan 'n groot risiko vir die pasiënt in. Medisyne-afleweringstelsels wat 
meer gelokaliseer kan word, kan blootstelling van die gasheer beperk. Hier word 
voorgestel dat 'n outoloë afleweringstelsel gebruik word om dwelms deur die sirkulasie 
te vervoer, wat die gasheer teen voortydige blootstelling aan medisyne beskerm. Ons 
het 'n multidissiplinêre benadering ingespan wat beide fisiologie en mikrobiologie 
insluit. Van die fisiologiese kant af besit makrofage die vermoë om dwarsbrekings deur 
die endoteel te maak gedurende die inflammatoriese proses. Van die mikrobiologiese 
kant af het mikroörganismes ontwikkel om die immuunstelsel te ontduik deur binne 
hierdie makrofage weg te kruip en later hul eie uitsetting vir verspreiding te 
bewerkstellig. Die werk wat hier aangebied word, beskryf hoe ons die porievorming en 
aktienpolimerisasie-vermoë van die Listeria monocytogenes-effektore listeriolysien-O 
en aktien-samestellende induserende proteïen gebruik het om 'n nuwe medisyne-
afleweringstelsel te vervaardig: die sintetiese mikroörganisme. Eerstens het ons 
hierdie effektore gesintetiseer deur gebruik te maak van 'n GFP-gekoppelde heteroloë 
uitdrukking- en suiweringstelsel, waarmee ons effektore met 'n groter opbrengs kon 
produseer as wat voorheen gerapporteer is. In vitro-resultate het die toepaslike 
aktiwiteit van gesintetiseerde proteïene verder bevestig. Laastens het die bedekking 
van hierdie effektorproteïene op polistireenkrale hul uitsetting uit draer-makrofage 
veroorsaak. Verder het die uitsetting van geneesmiddelvragte nie gelei tot lise van die 
draerselle nie, wat daarop dui dat makrofage kan bydra tot die genesing van skade in 
die teikengebiede nadat die vrag vrygestel is. Na ons mening kan hierdie 
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Chapter 1: Introduction 
Due to the time and cost involved in the research and development of novel 
pharmaceuticals, the approval of new antibiotics by regulatory bodies cannot keep up 
with the increasing multidrug resistance of many microbial pathogens. Furthermore, 
the increasing need for higher toxicity pharmaceuticals to eliminate these resistant 
bacteria or malignancies is associated with a plethora of undesired effects in the 
already compromised patient (Yasinzai et al., 2013; Hughes et al., 2015). Optimal 
delivery mechanisms are essential to ensure the effective delivery and release of 
these pharmaceuticals (cargo) and to limit side-effects. Apart from obvious problems 
such as toxicity, other problems are also encountered with systemic drug 
administration, which may affect drug efficacy. For example,  drugs may bind to serum 
proteins, which may either inactivate the drug or prevent it from reaching its intended 
target areas (Ahsan et al., 2002; Khan et al., 2002). Also, in chronic diseases such as 
cancer, the high potency drugs required for treatment often have severe side-effects 
resulting in other chronic diseases, e.g. the chemotherapeutic drug doxorubicin, which 
is linked to cardiotoxicity and eventual chronic heart failure (Schlame et al., 2000; Shi 
et al., 2011; Sishi et al., 2013 a;  b). Nanoscience has been incorporated in attempts 
to decrease occurrence of side-effects, but this has introduced new problems, for 
example in terms of pharmacodynamics. For example, doxorubicin has been 
packaged into liposome nanoparticles (Simpkins et al., 2013), however, these 
nanoparticles exhibited low tissue infiltration and the nanoparticle size generally limits 
delivery of larger drugs or proteins (Hoshyar et al., 2016). In addition, antimicrobial 
drugs have been reported to exert a plethora of neuropsychiatric effects (Zareifopoulos 
et al., 2017), such as anxiety, psychosis, mood disturbances, behavioural changes 
and seizures (Warstler et al., 2016). 
The use of biopharmaceuticals is becoming more prevalent due to their high specificity 
and potency. However, due to their structural complexity, these molecules are often 
relatively unstable, and their size complicates the process of traversing biological 
barriers such as mucosal membranes (Youshia et al., 2016). These issues regarding 
drug delivery have invoked research and development initiatives into several drug 
delivery systems, including the use of polymer based micro- and nano- particles, which 
generally utilise encapsulation techniques for packaging drugs for delivery (Ahsan et 
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al., 2002). The limitations and advantages of different drug delivery systems have 
been comprehensively reviewed (Mitragotri et al., 2014; Patra et al., 2018). Although 
advancements have been made over the past few years, it is important to consider 
that these drug delivery systems are markedly diverse with each comprising of its own 
benefits and limitations. I present a short summary of the literature on some drug 
delivery systems to illustrate their diversity, benefits and limitations in table 1.1. Here 
I will only mention a few of these which are most pertinent to my thesis topic. For 
example, one benefit (and reason for use) of microparticles include the ability to delay 
drug release (Cohen et al., 1991). However, microparticles run the risk of increasing 
the inner pH as it degrades in vivo, that could lead to degradation of protein or peptide 
based drugs (Ding et al., 2006). Nanoparticles on the other hand can be used as 
vaccine adjuvants (Zhao et al., 2014), however, vascular epithelial elicits low 
permeability for nanoparticles, lowering bioavailability in deep tissue. It has been 
suggested that this issue could likely be addressed by optimising the geometry of 
nanoparticles (Banerjee et al., 2016), but this remains to be substantiated. 
The quest for techniques to achieve successful focal in vivo delivery of 
pharmaceuticals or cargo – these may range from high-toxicity drugs to stem cells – 
thus remain an important niche within cell biology research and is of great clinical 
importance for future therapeutic interventions. Although a multitude of potential 
delivery systems have already been put forward, no broadly applicable delivery 
mechanism has been elucidated. It is clear that this problem can only be solved by 
taking an “out-the-box”, multidisciplinary approach. To this end, we believe that 
manipulation of an endogenous cellular “delivery system” would significantly address 
the above-mentioned limitations, limit the need for invasive surgery and allow delivery 
to normally inaccessible areas within bone or the central nervous system. Recently, 
we proposed packaging of cargo inside endogenous, living cells, for both protection 
and delivery to specific in vivo sites (Visser et al., 2019). More importantly – and the 
main topic for this project – we propose the development of a method for the release 
of cargo from these cells in a manner that is non-lytic to the host cell itself, so that drug 
delivery itself  would not add to the magnitude of inflammation at the site of delivery. 
Briefly, in my opinion, the monocyte/macrophage leukocyte subpopulation is the 
appropriate candidate for use as a delivery shuttle. (For a brief introduction of basic 
macrophage biology, please refer to  Appendix 1.) Most pertinent to the current thesis 
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topic, these robust cells elicit an unrivalled capacity for migration from the circulation 
into and through various tissue compartments, during normal functioning, to exert their 
roles in the inflammatory process (Arnold et al., 2007 a; Abbas et al., 2014). We have 
recently successfully manipulated macrophages to ingest different cargo – ranging 
from polystyrene particles to live muscle stem cells – without the cargo being digested, 
by experimentally inducing transient phagosome maturation arrest (Visser et al., 
2018). This approach immediately solves the problem of maintaining cargo intact for 
delivery, through shielding it from the in vivo environment until release. Furthermore, 
we have shown sustained phagocytic and transendothelial migration capacity of these 
manipulated, loaded, macrophages using in vitro models (Visser et al., 2018).     
Although these results are very positive and novel, and optimisation for in vivo 
conditions is ongoing, the next major obstacle is related to actual delivery of the drug 
at required sites. Importantly, the method of delivery should not exacerbate 
inflammation or other degradative processes, as this would compromise recovery rate 
and recovery quality. As mentioned, here we propose using an unconventional, 
multidisciplinary approach to achieve delivery of intact cargo from an endogenous live 
cell without damage to the host cell. This would involve “hijacking” the mechanisms 
used by microbes to induce their non-lytic release from cells during infection and in 
vivo dissemination. This would produce a “synthetic microbe” which effectively 
encapsulates the cargo inside a macrophage phagosome, to facilitate its controlled, 
acute burst release.  
In terms of dissertation layout, I provide an overview of the relevant literature in 
Chapter 2. This review has been published in Frontiers in Pharmacology in 2019 
(Visser et al., 2019). This review is followed by a formulation of my hypothesis and 
specific aims, with methods employed presented in Chapter 3. I present the most 
significant results in Chapter 4, before interpreting data and contextualising findings 
in terms of relevant literature in Chapter 5. Finally, I present final conclusions and 
suggestions for further investigations in Chapter 6. 
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Chapter 2: Literature Review 
This literature review has been published in its current form: Visser JG, Van Staden 
ADP, Smith C. (2019). Harnessing Macrophages for Controlled-Release Drug 
Delivery: Lessons from Microbes. Frontiers in Pharmacology 10:22, 1-18. doi: 
10.3389/fphar.2019.00022. Impact factor 3.845 
2.1. Introduction 
In recent years, drug delivery has become a well-documented research niche across 
various disciplines in science. Approaches of drug delivery into pathogenically 
damaged areas or poorly vascularised cancer tissues has been largely focused on 
treatments incorporating nanoparticles (Zhao et al., 2011; Dreaden et al., 2012; Feng 
et al., 2014; Huang et al., 2015; Lv et al., 2016; Tanei et al., 2016). These nanoparticles 
generally serve to shield harsh/labile drugs from the host and subsequently activate 
or release it after reaching target tissues. With the potential exception of nanoparticle 
uptake into target cells via complementary receptor ligands, this approach is however 
still more comparable to drug saturation than with specialised drug delivery per se. 
In this review we propose an alternative to the strategies/approaches used until now: 
a novel macrophage-mediated drug delivery method that more accurately fits the term 
“drug delivery”, via incorporation of both nanomedicine and cellular manipulation. 
Macrophages are highly mobile cells. By loading host macrophages with appropriate 
cargo (e.g. chemotherapeutic agents such as doxorubicin or high-potency 
antimicrobials), one can thus theoretically use the inherent homing capabilities of 
these immune cells to reach target damaged, infected or malignant tissue, in order to 
treat the affected cellular areas only. Such an approach would reduce the total 
concentration of drug required (when compared to systemic administration) and 
significantly reduce or even eradicate the risk of drug-associated adverse effects. 
Achieving this goal would indeed require substantial research into phagocytosis, 
macrophage chemotaxis, pathogenic immune evasion and controlled release of 
therapeutics. Here, we propose such a system where cargo is introduced into the 
macrophage, maintained within “inactivated” phagosomes and released in a controlled 
manner at the appropriate time and in vivo location.  
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The system as proposed in its entirety here, is novel. However, some aspects of this 
system have been investigated individually before (discussed in detail later) and 
testifies to the feasibility of the approach we suggest.  In order to fully understand 
cellular role players, a multidisciplinary approach is clearly required. We propose that 
the literature on host-microbe interactions may provide the insight required. While 
research have described the ability of microbes to evade the immune system by hiding 
(and proliferating) inside immune cells before orchestrating their own expulsion or 
transfer directly into new host cells, the mechanisms by which they achieve this have 
received very little attention by non-microbiologists. In our opinion, harnessing these 
microbial strategies could prove useful in the drug delivery niche. Thus, if a paradigm 
shift can be made to embrace the fact that host-affecting microbial mechanisms may 
potentially have therapeutic application, we believe that biologists could learn valuable 
lessons from microbes, to the benefit of technological advancement in medicine. 
The aim of this paper is therefore to present a summary of pertinent literature on 
microbial mechanisms known to modulate the course of endocytic processes and to 
evaluate their feasibility in the context of therapeutic drug delivery. A specific novel 
focus will be on potential mechanisms through which to achieve controlled expulsion.  
We believe that this paper elucidates an exciting new avenue for research in the 
context of drug delivery. 
In order to facilitate clarity of our argument, we first provide a brief overview of the 
most pertinent literature describing the mechanisms that would come into play in a 
complete cell-based delivery system.  Considering the complexity of these processes, 
one can appreciate the enormity of the task to elucidate which perturbations in this 
process may be used for application to our proposed drug delivery system.  Thus, we 
will describe the different phases – namely cargo loading, maintenance of cargo 
integrity, in vivo motility of the carrier cell toward delivery sites and cargo expulsion – 










2.2. Components of a Cell-Based Delivery System 
2.2.1. Cargo Loading into Macrophages 
Circulating monocytes form part of the innate immune system and are largely 
responsible for the initial recognition of foreign material or microbes (Abbas et al., 
2014). Recognition and internalisation, for the purpose of neutralisation, are generally 
very effective. This is evidenced by the absence of adaptive B and T cell responses in 
almost 95% of Animalia (Mills et al., 2015). However, many microbes have been able 
to survive within macrophages by manipulating phagocytic processes (discussed 
later). A summary of the most relevant normal human phagocytic processes is 
presented visually in Figure 2.1. 
Figure 2.1: Fundamental mechanisms 
of phagosome maturation. Initiated 
through (1) Recognition and engulfment 
of opsonised microbe and expression of 
phospholipids and phosphoinositide 3-
kinase (PI3k), at the extending 
pseudopodia. (2) Nascent phagosome is 
formed after actin polymerisation 
facilitates pseudopod closure behind the 
microbe. This phagosome is 
characterized by Rab5, 
phosphatidylinositol 3-phosphate (PI3P) 
and endosomal early antigen 1 (EEA1) 
expression. (3) The late phagosome is 
characterized by Rab7 recruitment; 
resulting in Rab5 inactivation and PI3P 
degradation as well as recruitment of 
lysosome-associated membrane 
proteins (LAMP) while achieving dynein 
linkage and centripetal movement for 
later lysosomal fusion. Rab7 achieves 
these processes via Rab7-interacting-
lysosomal-protein (RILP) and oxysterol-
binding protein related-protein 1 
(ORP1L). Lysosome fusion initiates the 
last stage in maturation; (4) 
Phagolysosome biogenesis, where 
LAMP expression is increased, and 
lysosomal content is dumped into the 
phagosome. Rab20 also allows an acidic 
environment through the action of 
vacuolar-type HC-ATPase (V-ATPase). 
 
The most important aspect of our topic is that of immune recognition and intake into 
the macrophage. It is commonly known that pattern recognition receptors (PRRs) on 
phagocytes recognise several different molecular patterns – such as damage-
associated molecular patterns (DAMPs) or pathogen-associated molecular patterns 
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(PAMPs) – on the target for potential phagocytosis (Abbas et al., 2014). Toll-like 
receptors (TLRs) present on phagocytes also indirectly regulate phagocytosis through 
Myeloid differentiation primary response 88 (Myd88) signalling and activation of the 
p38 residue (Shi et al., 2016). Several other minor role players in pathogen 
recognition, such as receptors for lectin, mannose, complement and Retinoic acid-
inducible gene-I-like (RIG-like) receptors, has been identified, but the immunoglobulin 
G (IgG) receptors are most directly associated with phagocytosis of material. In fact, 
antibody-opsonised material binds and activates IgG receptors to induce engulfment 
independently of co-stimulation by T cells or NK (natural killer) cells (Liu et al., 2013), 
making this mechanism an obvious choice for ex vivo cargo loading into macrophages. 
Engulfment is reliant on phosphoinositide 3-kinase (PI3k) recruitment and its 
production of various phosphatidylinositides that, together with actin polymerisation, 
result in pseudopod formation around the material and subsequent internalisation.  
Once material has been engulfed, it is enveloped inside a double-membraned 
(nascent) phagosome, which  is innocuous and undergoes various maturation phases, 
that culminates in fusion with lysosomes, which enables it to acidify and break down 
its contents. Characterisation of this maturation process is well-established (Patki et 
al., 1998; Fratti et al., 2001; Vieira et al., 2002; Kinchen et al., 2008; Fairn et al., 2012) 
and are not discussed in detail here, as we do not envisage a requirement for huge 
manipulation of this phase. Indeed, previous research by our group and others have 
demonstrated that macrophages readily take in a variety of purpose-designed 
materials and particles of varying sizes via endocytic pathways (Zhao et al., 2011; 
Dreaden et al., 2012; Feng et al., 2014; Oh et al., 2014; Huang et al., 2015; Miller et 
al., 2015; Tanei et al., 2016; Fan et al., 2018; Visser et al., 2018). 
2.2.2. Cargo Maintenance 
Of more direct relevance, lysosomal fusion marks the start of the last stage in 
maturation, that of phagolysosome biogenesis (Seto et al., 2011), which is an obvious 
threat to cargo maintenance. Normally, this lysosome fusion is mediated by 
endoplasmic reticulum (ER) soluble N-ethylmaleimide-sensitive factor-attachment 
proteins (SNARE) such as syntaxin 7, syntaxin 8 and vesicle associated membrane 
protein (VAMP) -7 and -8 (Becken et al., 2010). Lysosome-associated membrane 
protein (LAMP) concentration is increased after fusion (Jahraus et al., 1994) and 
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cathepsin D proteases are recruited from the Golgi via Rab-22b, -32, -34, -38 and -43 
(Ng et al., 2007). The vacuolar-type H+-ATPase (V-ATPase) is also incorporated via 
Rab20 co-localisation at this time (Curtis et al., 2005). In this way, fusion ultimately 
effectuate an acidic environment within the macrophage phagosome, as well as 
supplying it with proteases, reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) to facilitate decomposition of phagosomal content.   
To date, the majority of literature employing macrophages as delivery shuttles, have 
used either nanoparticle-encapsulated drugs travelling inside the cell, or drugs 
“backpacked” on the outside of the cell. The most popular protocol used are to load 
cargo into macrophages to create a “Trojan horse”. However, this approach has some 
limitations: firstly, there is a significant risk of drug-associated cytotoxicity, secondly, 
drugs are released at a relatively slow rate and thirdly, they are vulnerable to lysosomal 
degradation inside the macrophage (Yousefpour et al., 2014). In an attempt to address 
these limitations, transport of drugs on the outer surface of macrophages were 
attempted. However, prevention of internalisation of the backpacked cargo into carrier 
macrophages was a major obstacle (Watson et al., 2010; Doshi et al., 2011).  
In our opinion,  perhaps the most feasible option to ensure integrity of cargo that are 
either labile or highly toxic – so that premature delivery should not be risked – would 
be their maintenance intracellularly by modification of normal phagocyte function. It is 
here where we could substantially learn from microbial strategies (refer to Section 
2.4). Indeed, we have previously demonstrated maintenance of cargo inside primary 
human M1 macrophages chemically treated to transiently inhibit phagosomal cargo 
destruction (Visser et al., 2018). Briefly, protein-coated polystyrene beads, used as 
simulative cargo, were maintained intact (i.e. with no digestion of the protein coating) 
inside macrophages after in vitro treatment with a phagosome maturation inhibiting 
cocktail, consisting of Wortmannin, Concanamycin A and Chloroquine. This inhibition 
cocktail was only administered in vitro, and treated cells were washed prior to use, 
thus lowering risk to patient in the context of in vivo application. Furthermore, this 
intervention did not affect chemotactic or migratory capacity – macrophages were able 
to transverse an in vitro Human Umbilical Vein Endothelial Cell (HUVEC) membrane 
while carrying the bead cargo.  
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Another modern technique relevant here, is the use of nano- or microparticle 
encapsulation of drugs prior to loading into carrier cells (Dou et al., 2006; Zhao et al., 
2011; Blaudszun et al., 2014; Feng et al., 2014; Klyachko et al., 2014; Pang et al., 
2016; Tanei et al., 2016; Gnanadhas et al., 2017; Evans et al., 2018; Fan et al., 2018). 
In addition to host protection, polymeric particles may also be used for maintenance 
of drug integrity itself. Emerging evidence indeed indicates a role for polymeric 
particles as protective modality for both host and drug cargo. Cargo can be rendered 
innocuous via, for example, poly-(NIPA-co-AAm) (PNIPAAm) micelle or microbubble 
encapsulation. PNIPAAm micelles are reported to degrade in response to an increase 
in temperature above the lower critical solution temperature (Feng et al., 2014), 
enabling control over bio-activation of encapsulated drugs. As an example, these 
micelles could be incorporated during treatment of peripheral diseases, such as 
melanoma or myopathy, where an external stimulus can be administered to increase 
the local temperature and release drug cargo from PNIPAAm micelles. Incorporation 
of microbubbles together with nanoparticles has also shown some promise during in 
vivo delivery of resveratrol for treatment of cancer (Lv et al., 2016). In this study, 
resveratrol was loaded into acetylated β-cyclodextrin nanoparticles (PNP), which were 
then loaded into microbubbles. The outer microbubble coating served to protect the 
pH sensitive PNP while in circulation, whereas PNP in turn released resveratrol upon 
exposure to the low pH tumour niche. These studies indicate that polymeric particles 
may be powerful tools to incorporate into delivery systems to address current 
limitations. 
2.2.3. In Vivo Macrophage Migration for Cargo Delivery 
Literature focusing on macrophage (or other phagocyte) migration are normally aimed 
at the prevention of this migration, e.g. in the context of cancer metastasis or 
inflammation. Despite the different focus to ours, these studies have elucidated the 
process of migration in detail. 
For example, in the context of muscle inflammation, M1 macrophages have been 
illustrated to be the most motile, pro-inflammatory phenotype, while M2 macrophages 
are less likely to infiltrate tissues and associated with a relatively anti-inflammatory 
outcome (Arnold et al., 2007 a; Smith et al., 2008; Kruger et al., 2014). Our previous 
work on M1 macrophages (Visser et al., 2018) confirms the choice of this phenotype 
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as superior for drug delivery. However, it should be noted that macrophage phenotype 
has a large degree of plasticity, which will have to be taken into account when 
designing drug delivery protocols for application in particular disease states. To this 
end, a recent review (Ruytinx et al., 2018) comprehensively provide information on 
macrophage polarisation in the context of inflammatory diseases such as neurological 
disease, cancer, metabolic and cardiovascular disorders. 
Similarly, in terms of chemotactic signals for macrophage migration, chemotaxins 
generally expressed on tissue cells in many different disease conditions have been 
identified. Most notably, inflammation – which would be present in any disease state 
with a requirement for drug delivery – is known to result in increased levels of the 
chemokines macrophage migration inhibitory factor (MIF) and/or macrophage 
chemoattractant protein 1 (MCP-1 or CCL2), which are strong signals for macrophage 
recruitment into the tissue (Lee et al., 2010; Baeck et al., 2012). Additionally, oxidative 
stress – which is a known complication of both chronic disease and infection (Nimse 
et al., 2015; Petersen et al., 2016) – have been shown to initiate macrophage migration 
in vivo (Wang et al., 2016). In terms of systemic migration towards chemotactic signals 
originating from hypoxic tissue, such as in cancer, evidence also exist to confirm the 
inherent capacity of macrophages to migrate toward tumours (Owen et al., 2004; 
Batrakova et al., 2011). Although finer detail on the regulation of macrophage 
migration has been reported, such as its dependence of on integrin β1 expression and 
recycling (Gnanadhas et al., 2017) and numerous proteases (Van Goethem et al., 
2010), these details are likely of academic value only, at least for the context under 
discussion. In our opinion, these factors are unlikely to be a limiting factor, since 
integrin β1 is expressed by almost all cell types and some degree of redundancy is in 
place. For example, in contrast to the fairly uniform amoeboid movement of 
neutrophils, macrophages were reported to exhibit multiple different migration 
mechanisms that are more mesenchymal in nature (Van Goethem et al., 2010; Barros-
Becker et al., 2017), which could confer greater resilience to macrophages in terms of 
mobility under adverse conditions. Interestingly, the latter study also demonstrated a 
greater degree of directionality of macrophages vs. neutrophils in a zebrafish tail 
transection model of leukocyte migration. Another ability of macrophages pertinent to 
the current topic, is their ability to maintain their mobility after ingestion of cargo, even 
when the cargo is much larger than anticipated to be required for the purpose of drug 
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delivery (Chang et al., 2013; Evans et al., 2018; Visser et al., 2018). These reports 
again confirm that this phase of the system is unlikely to require major intervention, as 
it seems to already have been fine-tuned by evolution. 
The only potential limitation we foresee is interference with chemotactic signal 
originating from the intended site for drug delivery, by e.g. an acute, severe 
infection/damage in another organ, which may have chemotactic priority above that of 
the signal originating from the intended delivery site. However, the practise of isolating 
patients for a period prior to a medical procedure is not uncommon and could avoid 
this complication. Furthermore, pathogen-associated infection has been shown to take 
priority above other, relatively less life-threatening, situations, which would in fact 
favour directional macrophage migration, rather than limit it.   
2.2.4. Cargo Expulsion 
The final step to complete such a delivery system, would be a mechanism by which 
the cargo can be released or expelled at the appropriate time and location in vivo. 
Normally, following phagolysosomal destruction of ingested material, digested 
material is either recycled by the phagocytic cell or expelled into the extracellular 
matrix. Recycling of re-usable “waste” such as amino acids, glucose and phosphates 
occur via diffusion through the phagolysosome membrane into the cytosol (Guyton et 
al., 2011). Of particular interest here, the insoluble components are expelled from the 
macrophage either via the ER-Golgi secretory pathway or utilised for antigen 
presentation through Ca2+- and vesicle-associated membrane protein 7 (VAMP7)-
dependant lysosome exocytosis (Samie et al., 2014). We believe that the manipulation 
of these expulsion mechanisms could facilitate controlled drug delivery. 
In terms of published studies on drug delivery systems, most systems either rely on 
non-specific release of nanoparticles containing drugs (Miller et al., 2015), or employ 
release of drugs inside the carrier cell. For example, rupture of doxorubicin-containing 
microbubbles inside macrophages was achieved by high intensity focussed ultrasound 
techniques (Fan et al., 2018). However, this strategy for drug release resulted in 
significant carrier cell death. We believe this is an undesirable mechanism, as this 
would likely contribute to inflammation and thus delayed recovery.  Therefore, to date, 
a controlled cell-based drug release system does not seem to exist. 
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In the next section, we evaluate microbially employed strategies, in terms of their 
feasibility for adaptation into therapeutic contexts. We will focus on the two phases of 
this system which seems to be most commonly and effectively manipulated by 
microbes, namely immune evasion by intracellular survival and programmed expulsion 
from host cells.  
2.3. What Can We Learn from Microbes? 
Pathogenic phagosome maturation arrest or modulation thereof, and subsequent 
escape from the host cell are hallmarks of bacterial host immune evasion and 
dissemination. Well characterized mechanisms include interfering with PI3k and PI3P 
biogenesis (M tuberculosis & Candida glabrata) (Vergne et al., 2003; Rai et al., 2015), 
establishing microbe-containing vacuoles  (Legionella pneumophila & Brucella) (Celli, 
2015; Bärlocher et al., 2017), blocking of fission and fusion with lysosomes and 
endosomes (Mycobacterium tuberculosis & Legionella) (Vergne et al., 2003, 2005; 
Bärlocher et al., 2017), raising pH levels via induction of phagosomal acid leakage 
(Cryptococcus neoformans) (Tucker et al., 2002), lysis of the phagosomal membrane 
(Listeria monocytogenes) (Alberti-Segui et al., 2007), hijacking of the endocytic 
recycling pathway (Legionella pneumophila) (Xu et al., 2013) and even active 
macrophage killing (filamentous Candida albicans) (Gaur et al., 2013). Manipulation 
of the endocytic pathways by microbes is achieved via highly diverse and complex 
mechanisms. Intracellular microbes secrete hundreds of proteins, known as effectors, 
capable of modulating these pathways (Santos et al., 2015; Schroeder, 2018). These 
effectors have diverse functions and microbes employ multiple layers of redundancy 
to ensure their survival (Ghosh et al., 2017; Schroeder, 2018). The abundance and 
variety of these effectors provide an ideal bioprospecting opportunity to identify 
effectors that can be utilized to modulate the endocytic pathways as needed. Keeping 
in mind that not all microorganisms have effectors capable of manipulating the 
endocytic pathway for both maintenance and expulsion. Identified effectors can then 
be further investigated to optimise the cocktail of effectors (possibly from different 
organisms) best suited for application in a macrophage-based delivery system.  
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Table 2.1: Examples of intracellular microbes and main outcomes of endocytic pathway 
modulation. Gram negative (G-), Gram positive (G+). *1 (Pizarro-Cerdá et al., 1998; Hong et al., 2000; Comerci et 
al., 2001; Boschiroli et al., 2002; Celli et al., 2003; Arellano-Reynoso et al., 2005; Celli, 2006; Pei et al., 2006, 2008; Starr et al., 
2008; Chen et al., 2009, 2011; Starr et al., 2012; von Bargen et al., 2012; Smith et al., 2016). *2 (Kirby et al., 1998; Roy et al., 
1998; Gao et al., 1999; Alli et al., 2000; Gerhardt et al., 2000; Bachman et al., 2001; Tilney et al., 2001; Molmeret, 2002; Chen et 
al., 2004; Molmeret et al., 2004; Chen et al., 2007; Xu et al., 2013; Schroeder, 2018). *3 (Smith et al., 1995; Skoble et al., 2000; 
Veiga et al., 2005; Henry et al., 2006; Shaughnessy et al., 2006; Alberti-Segui et al., 2007; Birmingham et al., 2008; Czuczman 
et al., 2014; Mitchell et al., 2015). *4 (Perfettini et al., 2003; Rzomp et al., 2003; Scidmore et al., 2003; Hybiske et al., 2007; Betts-
Hampikian et al., 2010; Capmany et al., 2010; Chin et al., 2012; Volceanov et al., 2014). *5 (Sturgill-Koszycki et al., 1994; Ferrari 
et al., 1999; Renshaw et al., 2002; Walburger et al., 2004; Vergne et al., 2005; de Jonge et al., 2007; Seto et al., 2010; Wong et 
al., 2011; Simeone et al., 2015; Zhang et al., 2016; Augenstreich et al., 2017; Queval et al., 2017; Quigley et al., 2017). *6 (Hersh 
et al., 1999; Steele-Mortimer et al., 1999; Jesenberger et al., 2000; Sano et al., 2007; Bujny et al., 2008; Mallo et al., 2008; 
Bakowski et al., 2010; Braun et al., 2010; McGourty et al., 2012; Chakraborty et al., 2015; D’Costa et al., 2015; LaRock et al., 
2015; Li et al., 2016; Knuff et al., 2017). *7 (Wozniak et al., 2008; Johnston et al., 2010; Nicola et al., 2011; Qin et al., 2011; 
Nicola et al., 2012; Chen et al., 2015; Davis et al., 2015; Smith et al., 2015; Bojarczuk et al., 2016; Gilbert et al., 2017). 
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Examples of intracellular microbes and their mechanisms for modulation of the 
endocytic pathway are summarised in table 2.1. In order to provide more detail on 
the variety and complexity of methods used, modulatory mechanisms of different 
microbes in the context of both phagosome maturation and expulsion are presented 
in the next sections. 
2.3.1. Intracellular Survival Mechanisms 
Due to the high incidence of tuberculosis in especially developing countries, much 
research has been focused on the causative agents of this illness. As a result, 
relatively detailed knowledge is available on the route of immune evasion by this 
pathogen in particular, as well as on how bacterially secreted effectors and cell wall 
components modulate phagosome maturation. The primary route of Mycobacterium 
tuberculosis (Mtb) into the body is through inhalation, where it reaches the lungs’ 
alveolar space and is preferentially taken up by alveolar macrophages. Mtb survive 
intracellularly by working against PI3ks to prevent EEA1 docking. This is achieved in 
two ways: 1) Mtb secretes a PI 3’-phosphatase (SapM) that dephosphorylates PI3P 
and 2) a component in the microbial cell wall, lipoarabinomannan (LAM), interferes 
with recruitment/activation of the human PI3k (hVPS34) (Vergne et al., 2005). 
Mycobacterium-containing phagosomes also retain the tryptophan-aspartate 
containing coat (TACO) protein (normally expressed on the cytosolic leaflet of the 
plasma membrane and involved in intracellular membrane trafficking, cytokinesis and 
cytoskeletal remodelling) (Ferrari et al., 1999). TACO retention causes prolonged 
Rab5 expression - although some maturation effectors can still bind the phagosome, 
this effectuates a relative absence of PI3P, so that the FYVE domain-mediated binding 
of EEA1 is greatly perturbed (Simonsen et al., 1998) and lysosome fusion inhibited 
(Ferrari et al., 1999). Additionally, secretion of the soluble serine/threonine kinase 
Protein kinase G (PKG) by Mtb into the host cytosol is essential for prevention of 
phagosome-lysosome fusion (Walburger et al., 2004). Furthermore, a more alkaline 
and hydrolase deficient phagosome is also brought about in two ways. Firstly, 
hydrolysis is weakened by limited expression of Rab7. This GTPase has been shown 
to only transiently localise to mycobacterial phagosomes, preventing sufficient Rab7-
interacting lysosomal protein (RILP) recruitment, but also limiting cathepsin D protease 
delivery (Seto et al., 2010, 2011). Secondly, acidification is regulated by Mtb by 
interfering with V-ATPase complex assembly and retention, thereby maintaining a 
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stable, slightly alkaline pH (6.2-6.5) (Sturgill-Koszycki et al., 1994; Seto et al., 2011; 
Queval et al., 2017). The Mtb phosphatase, PtpA, is involved in inhibition of complex 
assembly by binding to the subunit H of the V-ATPase where it then dephosphorylates 
and inactivates hVPS33B, effectively inhibiting the membrane fusion machinery 
(Wong et al., 2011).   
In contrast to Mtb, the survival mechanisms of C. glabrata is largely dependent on 
active PI3ks. C. glabrata encodes the enzyme PI3k and produces fungal PI3P (Strahl 
et al., 2007; Rai et al., 2015). In this manner, the PI3P content of phagosomes increase 
prematurely during the early stages of maturation, where PI3P has not yet come into 
play. This could lead to a PI3P rich phagosome being identified as already partly 
matured, thus halting further maturation. Additionally, increased PI3P content could 
overburden PI3P degradation capacity of the phagosomal lumen. Deletion of the 
functional subunits of fungal PI3k led to ameliorated phagosome maturation and 
significantly reduced fungal survival and virulence (Rai et al., 2015).  The differences 
between the strategy of C. glabrata vs. Mtb illustrates how the same cellular role 
players may be modulated in different ways for different outcomes, depending on the 
intended requirement of the modulating microbe, and in our opinion also demonstrates 
the susceptibility of this system to exogenous modulation or control. 
Reminiscent of Mtb, Leishmania (the causative agent of Leishmaniasis) promastigotes 
are also harboured in phagosomes that retain TACO on their membranes, blocking 
lysosome fusion and ensuring a neutral pH in which this parasite can differentiate into 
the amastigote stage (Ferrari et al., 1999; Gogulamudi et al., 2015). However, after 
differentiation, the parasite allows phagosome fusion with lysosomes to achieve an 
acidic environment in which the amastigotes thrive. Interestingly, these phagosomes 
still exhibit low expression of late phagosomal markers (LAMP, V-ATPase and Rab7), 
after lysosome fusion (Vinet et al., 2009). In addition, Leishmania protects itself by 
inhibiting recruitment of NADPH oxidase to the phagosome, perturbing ROS 
production (Moradin et al., 2012). Similarly, M. tuberculosis was reported to stimulate 
release of TNF-α and IL-10 from infected macrophages (Sendide et al., 2005), 
resulting in a deactivation of ROS and RNS release (Redpath et al., 2001). IL-10 
specifically down-regulates secretion of pro-inflammatory cytokines (Redpath et al., 
2001) like INF-γ and TNF-α and results in a shift toward a Th2-type cell expansion in 
the alveoli (de Almeida et al., 2012), bringing about a shift towards an alternatively 
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activated, anti-inflammatory, M2 macrophage phenotype (Smith et al., 2008), which 
itself produces more IL-10, sustaining this phenotype and a relatively more anti-
inflammatory environment.  This implies that these microbes not only alter the 
response of the host cell to the ingested microbe itself, but that it may also affect 
systemic signalling by the host cell, which may affect the rate at which these bacteria 
are able to spread. 
Brucella and Legionella are examples of intracellular pathogens that manipulate the 
endocytic pathway to create a niche in which they can replicate and thrive. They 
accomplish this by hijacking host proteins and membrane organelles to establish a 
bacterium-containing vacuole with morphological features reminiscent to that of host 
membrane compartments (Xu et al., 2013; Celli, 2015). Effectors secreted by Brucella 
within the Brucella-containing vacuole (BCV) manipulates maturation by altering 
interactions with late endosomes and lysosomes (Celli, 2015). During initial 
phagocytosis a large portion of Brucella cells are rapidly degraded (~90%), however 
surviving cells are capable of prolonged intracellular proliferation (von Bargen et al., 
2012). Previously it was thought that Brucella evade fusion of BCVs with lysosomes 
by secretion of effectors via a functional VirB type IV secretion system (T4SS) and 
cyclic β-1-2-glucan (Pizarro-Cerdá et al., 1998; Celli et al., 2003; Arellano-Reynoso et 
al., 2005). Cyclic β-1-2-glucan was thought to prevent fusion of the BCV with 
lysosomes by modulating lipid raft organization on phagosome membranes but is not 
a requirement for subsequent BCV maturation (Arellano-Reynoso et al., 2005). 
Rather, live cell imaging has shown that the BCV interacts with lysosomes, thus fusion 
is not completely prevented (Starr et al., 2008). Early stages of BCV maturation involve 
the recruitment of late endosome markers, LAMP-1 and Rab7 to the BCV membrane, 
with acidification of the BCV being crucial for VirB expression (Boschiroli et al., 2002; 
Starr et al., 2008). This early BCV is also known as the endosomal BCV (eBCV) due 
to its interaction with the endocytic pathway. These findings highlight the importance 
of the initial interactions with the endocytic pathway in determining outcome. Unlike 
Brucella, Legionella diverts from the canonical endocytic pathway soon after being 
phagocytosed (Tilney et al., 2001). Departure from the canonical endocytic pathway 
starts minutes after being phagocytosed – the Legionella-containing vacuole (LCV) is 
covered with smooth vesicles, ER in origin, and mitochondria is recruited to the LCV 
(Tilney et al., 2001). The LCV is also devoid of early endosome markers such as Rab5 
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and LAMP-1, with the exception of Rab7 (Roy et al., 1998). L. pneumophila utilizes 
early mild caspase-3 activation to prevent lysosome fusion by cleavage of rabaptin5 
(effector of Rab5) (Gao et al., 1999; Molmeret et al., 2004). The eBCV and LCV both 
eventually interact with components of the ER. In the case of the eBCV, LAMP-1 is 
progressively lost as the eBCV interacts with the ER and maturation proceeds to the 
formation of a replication-permissive BCV (rBCV) (Celli et al., 2003; Celli, 2006; Starr 
et al., 2008), with the rBCV subsequently converted from an intermediate vacuole into 
an ER-derived organelle which is ideal for bacterial proliferation (Celli et al., 2003). 
The smooth vesicles recruited to the LCV early on, eventually come to resemble rough 
ER and become studded with ribosomes (Gerhardt et al., 2000; Tilney et al., 2001). 
The specific recruitment of GTPases usually required for fusion of ER-derived vesicles 
with the Golgi apparatus aids in this process. Similar to Brucella, the hijacking of the 
host’s secretory trafficking pathway results in a replication-permissive LCV. The rapid 
formation of an ER-like LCV and subversion of the endocytic pathway is dependent 
on the Dot/Icm T4BSS (Defective in Organelle Trafficking/Intra-Cellular Multiplication 
Type 4B Secretory System) of Legionella (Roy et al., 1998). Indeed, mutants deficient 
in the T4BSS ultimately fuse with the lysosome, indicating that effectors secreted by 
the T4BSS directly influence the endocytic pathway (Roy et al., 1998; Molmeret et al., 
2004; Schroeder, 2018). The Dot/Icm T4BSS secretes hundreds of potential virulence 
effector molecules that aid in the formation of the LCV. However, no one effector has 
been shown to be crucial, again indicative of multiple layers of redundancy (Schroeder, 
2018). Similarly, the VirB T4SS is essential for Brucella survival, as illustrated in virB–
mutants (Hong et al., 2000; Comerci et al., 2001; Celli et al., 2003; Pei et al., 2008). 
Several other pathogens utilize T4SS and other secretion systems to release effector 
molecules that are capable of manipulating host function. The VirB and Dot/Icm 
systems are certainly also capable of releasing effector molecules that, in the case of 
Brucella and Legionella, are used to manipulate ER membrane dynamics and fusion.  
Similar to some vacuole-inhabiting bacteria, Chlamydia also subverts the endocytic 
pathway to create a replicative niche. Chlamydia is also a very proficient modulator of 
the host cytoskeleton through complex interactions of its secreted effectors with the 
host cell. This manipulation is even more interesting when considering that Chlamydia 
has a relatively small genome for bacteria (1.04 Mb and 1.23 Mb for C. trachomatis 
and C. pneumoniae respectively) and relies on the host for their metabolic 
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requirements (Stephens et al., 1999). Furthermore, ~10% of its genome encodes for 
virulence effectors (Betts-Hampikian et al., 2010) which, as for some other intracellular 
pathogens, are delivered through specialized secretion systems. Similar to Legionella, 
the Chlamydia-containing inclusion (the term used for the replicative vacuole) is 
diverted from the endocytic pathway early on and is rather trafficked to the microtubule 
organizing centre (MTOC) via dynein-mediated movement. From here, they are in an 
ideal position to intercept lipids and nutrient-rich exocytic vesicles. Markers for early 
endocytic- and late endocytic-compartments are absent from the inclusion (such as 
Rab5, Rab7 and LAMP-1) (Rzomp et al., 2003; Scidmore et al., 2003). However, 
several other Rab GTPases are recruited to the inclusion, such as Rab1, -4, -6 (C. 
trachomatis only), -10 (C. pneumoniae only), -11 and -14 (Rzomp et al., 2003; 
Capmany et al., 2010). The recruitment of the different Rab GTPases is important for 
the modulation of fusion events, for example the prevention of lysosomal fusion and 
promoting of fusion with lipids and nutrient-rich exocytic vesicles. Chlamydia further 
modulate vesicle fusion via interaction with SNARE proteins. 
Subversion of the canonical phagocytic pathway by Salmonella uses similar 
mechanisms to that of, both, the vacuole-residing bacteria and those opting for a 
cytosolic lifestyle. After internalization, Salmonella remains in a modified phagosome 
– the Salmonella containing vacuole (SCV). Similar to the microbes already 
mentioned, Salmonella utilize secretory systems to deliver their effectors to the host 
and have two T3SS encoded on different pathogenicity islands (SPI-1 and SPI-2) 
(LaRock et al., 2015). The early effectors secreted by Salmonella (via T3SS-SPI1) are 
important for the establishment of this early SCV. Shortly after being phagocytosed 
SCV associates with early endosome markers EEA-1 and Rab5 and via its effector 
SopB (a phosphatase), delays lysosome fusion by indirectly preventing Rab GTPases 
from binding to the phagosomal membrane (Steele-Mortimer et al., 1999; Mallo et al., 
2008; Bakowski et al., 2010). Recruitment of sorting nexins (SNX) help in the 
progression of SCV maturation, SNX1 specifically induces tubulation and is involved 
in the removal of the cation-dependent mannose-6-phosphate receptor (MPR) that 
may be important for the lack of lysosomal enzymes in the late SCV (Bujny et al., 
2008). Additionally, SNX3 transiently interacts with the early SCV and is required for 
tubule formation and recruitment of late endosomal markers Rab7 and LAMP-1 (Braun 
et al., 2010). The replacement of early markers at this stage is accompanied by a 
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decrease in both bacterial cytoplasmic and SCV pH (Chakraborty et al., 2015). This 
drop in pH is crucial for induction of SPI-2 genes required for subsequent effector 
secretion. The effectors secreted by T3SS-SPI-2 change the early SCV into a late 
SCV that is uniquely suited for bacterial replication. Examples of SPI-2 effectors 
involved in SCV maturation include SifA and SopD2. SifA complexes with SifA-and-
Kinesin-Interacting-Protein (SKIP). The SifA-SKIP complex sequesters and binds 
Rab9, thereby inhibiting Rab9-dependent recruitment of MPR (McGourty et al., 2012). 
SopD2 impairs the Rab7-dependent recruitment of RILP and FYCO1 (FYVE and 
Coiled-coil domain Containing protein 1). RILP and FYCO1 are involved in vesicular 
trafficking along microtubules and indirect inhibition of their recruitment by SopD2 
delays delivery of the SCV to lysosomes (D’Costa et al., 2015). At this stage, the SCV 
is similar to a late endosome (with markers LAMP-1, Rab7 and V-ATPase), but not 
enriched with lysosomal enzymes, possibly due to the lack of MPR and incomplete 
lysosome fusion (McGourty et al., 2012). Similar to Chlamydia, Salmonella exploit 
dynein-mediated transport (via its effectors) to arrive at a juxtanuclear position near 
the microtubule organizing centre (MTOC). At this location, Salmonella distinguishes 
itself from other intracellular pathogens with the formation of a dynamic tubular 
network composed of Salmonella induced filaments (SIFs) (Knuff et al., 2017). SIFs 
are required for SCV integrity, enabling continuous fusion of host vesicles to SCV and 
are associated with late endosomal markers such as LAMPs, Rab7, V-ATPase, 
cholesterol and lysobisphosphatidic acid (LBPA), as well as low levels of MPR and 
cathepsin D. Furthermore, another similarity with other vacuole-living bacteria, is the 
communication between the SCV and the ER, illustrating the extensive interactions of 
SIFs/SCV with the host cell (Santos et al., 2015). However, unlike the other vacuolar 
bacteria’s interaction with ER-derived components, the Salmonella SCV interaction 
with the ER-derived coat protein complex II (COPII) can result in SCV rupture and 
Salmonella hyper-replication in the cytosol (Santos et al., 2015). 
In comparison to the more meticulous modulations mentioned, L. monocytogenes 
takes a relatively more radical (and perhaps destructive) approach to ensure 
intracellular survival. Manipulation of the clathrin-mediated endocytic pathway 
facilitates entry into non-phagocytic cells (Veiga et al., 2005), whereas entry into 
macrophages is achieved via phagocytosis and initial engulfment of bacteria to form 
phagosomes. However, with the help of the cholesterol-dependent pore forming toxin 
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listeriolysin-O (LLO), phagosome-lysosome fusion is disrupted via dysregulation of pH 
and calcium gradients across the phagosome membrane (Henry et al., 2006; 
Shaughnessy et al., 2006). Additionally, with the help of two phospholipases (PlcA and 
PlcB), LLO promotes escape of the bacteria from phagosomes into the cytosol (Smith 
et al., 1995; Mitchell et al., 2015). Once in the cytosol, bacteria undergo rapid growth 
and subsequently hijack the host’s actin polymerisation machinery to move within the 
cytosol and ultimately spread in a cell-to-cell manner (Skoble et al., 2000; Mitchell et 
al., 2015). Although not as intricate as Brucella and Legionella, Listeria is also capable 
of slow replication in macrophage vacuoles (instead of rapid cytosol replication) via 
the formation of spacious Listeria-containing phagosomes (SLAPs) (Birmingham et 
al., 2008). SLAP formation is dependent on LLO, but unlike phagosome rupture 
observed with cytosolic life, intermediate LLO expression is required for interference 
with phagosomal pH, without phagosomal rupture. Bacteria containing SLAPs are 
LAMP-1+, which indicates that these are endocytic compartments. However, no drop 
in pH is observed, due to LLO-mediated uncoupling of pH gradients across the 
membrane and prevention of lysosome fusion. Furthermore, SLAP formation is 
dependent on autophagy and is hypothesized to be triggered by the damage caused 
to phagosomes by LLO.  
The opportunistic pathogen Cryptococcus neoformans (Cn) is also capable of infecting 
and replicating at high numbers in macrophages and may possibly utilize these 
phagocytes as shuttle for their dissemination across the blood brain barrier. An 
important virulence factor of Cn is its capsule, which ensures survival by protecting 
against phagocytic uptake and oxidative stress, once infiltrated into the host circulation 
(Zaragoza et al., 2008; Bojarczuk et al., 2016). However, phagocytosis can be 
triggered by direct recognition of Cn capsule components or indirectly via complement 
(Johnston et al., 2013). After Cn internalisation by macrophages, it resides in 
phagosomes which mature into a phagolysosome, as usual. Interestingly, this microbe 
does not seem to radically modulate the phagosomal maturation process, but rather 
seems able to thrive at the lower pH of the maturing phagosome. Some early- and 
late-endosomal markers are present on these phagosomes, including EEA-1, Rab5, 
Rab11, MPR, LAMP-1 and cathepsins, with live Cn inducing premature removal of 
Rab5 and Rab11 from the Cn phagosome, which may influence phagosome 
acidification (Tucker et al., 2002; Davis et al., 2015; Smith et al., 2015). The 
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phagolysosomes still acidify, but final pH is maintained slightly higher, at around 5.3 
(vs. normal phagolysosome pH of ~4.5), which is the optimal pH for Cn growth. 
Additionally, damage to the phagolysosome membrane favours Cn survival and 
possibly contributes to the slight increase in pH observed with live Cn (Davis et al., 
2015). Recently urease activity was found to influence phagosomal pH, which through 
production of urease-derived ammonia can increases pH (Lerm et al., 2017; Fu et al., 
2018). Furthermore, membrane damage to the phagolysosome results in 
permeabilization of the membrane and subsequent leakage of lysosomal enzymes 
(e.g. cathepsins), the loss of which may also increase survival of Cn within the 
phagolysosome (Wozniak et al., 2008). Furthermore, the release of these enzymes, 
can result in activation of inflammasomes and subsequent cell death (Chen et al., 
2015). It is clear that Cn is capable of modulating phagosome maturation to some 
extent, but the search for responsible effectors is still ongoing. 
These studies illustrate how some pathogens manipulate the phagocytic process in 
seemingly divergent ways to reach an identical end goal of intracellular survival. In 
doing so they ensure their own propagation and dissemination to elicit disease. 
Importantly, in our opinion, this demonstrated susceptibility to manipulation of the 
phagocytic process supports the feasibility of drug delivery systems that harness one 
or more of the microbial strategies presented here. Although there is still much 
research to be done on the exact microbial effectors involved in manipulation of the 
endocytic pathway, the available literature can already be used to make informed 
decisions as to which effectors can be used in the development of autologous drug 
delivery systems.  
In the context of a complete macrophage-based drug delivery system, the 
manipulation of the endocytic pathway for retention and protection of cargo is only the 
first step. The next step to consider in the development of an effective delivery system, 
is the expulsion of drug cargo from macrophage vehicles. To this end, the mechanisms 
used by microbes can again be mined and possibly exploited to achieve cargo 
expulsion. 
2.3.2. Expulsion from Host Cell 
Turning attention now to the expulsion phase, which is a vital requirement for 
pathogenic dissemination of microorganisms, and which can be induced by either the 
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infected host cell, or by the pathogen itself. Some microorganisms utilise host cell 
machinery to facilitate their escape, while others induce either accidental or intended 
host cell death, resulting in their release from the cell as a “side-effect”. Many 
microorganisms have been identified to have the ability to egress via one or more 
methods and some effectors in this process have been identified. However, in terms 
of manipulation of egress through upregulation or elimination of these effectors, very 
little data is available and substantial experimental work is still required in this niche. 
This can be attributed, at least in part, to a large degree of redundancy. This degree 
of redundancy is also seen in the bacterial mechanisms employed to modulate 
phagosome maturation, which adds complexity to the process of identifying a 
controllable pathway. Below, we provide a summary of the current knowledge 
regarding microbial egress, with an integrated discussion of its potential for therapeutic 
application. 
Probably the most obvious technique used, given the ability of many microbes to 
manipulate phagosomal pH for intracellular survival, is the manipulation of pH to 
induce host cell death. This technique has been described in some detail for Mtb, 
which stabilises phagosomal pH at ~6.2-6.5 by interfering with the V-ATPase complex 
(Sturgill-Koszycki et al., 1994; Seto et al., 2011; Queval et al., 2017). This raised pH 
level is a pre-requisite for the ESX-1 dependent rupture of the phagosome (Simeone 
et al., 2015).  The ESX-1 (T7SS) secretory system secretes two effector proteins, 
namely EsxA and EsxB, which form a heterodimer and are secreted by Mtb in a co-
dependent manner (Renshaw et al., 2002). EsxA has membrane permeabilizing 
properties and EsxB is thought to act as a chaperone to prevent degradation and/or 
premature lytic activity (de Jonge et al., 2007; Zhang et al., 2016). EsxA effects 
phagosome rupture and escape to the cytosol, while being aided by the cell wall lipid 
phthiocerol dimycocerosates (PDIM) (Augenstreich et al., 2017; Quigley et al., 2017). 
This lipid has been proposed to primarily aid in phagosomal rupture, resulting in 
increased numbers of cytosolic bacteria – which in turn induces host cell necrosis and 
ultimately Mtb dissemination (Augenstreich et al., 2017; Quigley et al., 2017). 
Other bacteria have also been described to escape through host cell membrane 
rupture resulting in cell death, albeit achieved by slightly different techniques. Brucella 
for example replicates within host cells, dissociating into two phenotypes, namely a 
smooth and a rough type. The rough phenotype has cytotoxic activity which breaks 
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down the cellular membrane and is essential for bacterial dissemination (Pei et al., 
2006, 2014). In this way, Brucella egress and dissemination are achieved through 
caspase-2 mediated cell death (Chen et al., 2009, 2011). Furthermore, this mode of 
cell death results in a pro-inflammatory response and recruitment of additional 
macrophages - that can be infected - in further aid of  Brucella dissemination (Pei et 
al., 2014). It has however been proposed that Brucella can disseminate via cell-to-cell 
spread using an autophagy related mechanism (Starr et al., 2012; Smith et al., 2016). 
The final phase of Brucellas’ intracellular life cycle is the formation of an aBCV which 
results from the engulfment of rBCVs into autophagosome-like structures via an 
autophagic process (Starr et al., 2008, 2012). This transformation to an aBCV is an 
essential prerequisite for bacterial egress via cell-to-cell spread (Starr et al., 2012; 
Smith et al., 2016). Interestingly, the VirB T4SS has been implicated in Brucella 
release via cell death and cell-to-cell spread, although the bacterial effectors have not 
been identified (Pei et al., 2008; Smith et al., 2016). The different modes of 
dissemination are possibly due to differences in experimental conditions, such as 
bacterial strains and cell lines used. Different bacterial strains may have different 
effectors or altered expression profiles that may result in different post-replicative 
outcomes (i.e. cell death or cell-to-cell spread) and different cell lines will also react 
differently to secreted effectors. 
Legionella can also be placed in the category of intracellular pathogens that escape 
through macrophage cell death. Once a replicative LCV is established inside the 
macrophage, the bacteria converts to a replicative form and multiplies within the 
enclosed LCV. At high multiplicities of infection and subsequent termination of 
replication Legionella exhibit contact-dependent cytotoxicity, resulting in formation of 
pores in the host cell membranes (Kirby et al., 1998; Bachman et al., 2001). Initially 
pores are formed within the phagosomal membrane (of the LCV), resulting in release 
of bacteria into the cytosol. The cytosolic bacteria are then able to form pores within 
the plasma membrane, resulting in osmotic lysis and release of bacteria (i.e. necrosis) 
(Kirby et al., 1998; Alli et al., 2000). The importance of the Dot/Icm secretory system 
of Legionella for pore-formation mediated lysis, and specifically that of the small inner 
membrane protein, IcmT, has been illustrated (Molmeret, 2002). Interestingly, in 
primary protozoan host cells, Legionella is capable of non-lytic release. The bacterial 
effectors LepA and LepB have been shown to play a role in manipulating the amoeba 
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hosts exocytic pathway for dissemination (Chen et al., 2004, 2007). These effectors 
may also play a role in Legionella release from human cells or phagosome maturation 
and can potentially form part of an artificial microbe drug delivery system. 
Literature indicates that Salmonella exits cells via several mechanisms, including 
programmed cell death and flagella-facilitated escape. For example, the SPI-1 effector 
SipB can act by inducing caspase-1-dependent pyroptosis in macrophages (Hersh et 
al., 1999; Li et al., 2016). Briefly, SipB binds to and activates caspase 1, resulting in 
the cleavage of pro-IL1β and its secretion (Hersh et al., 1999; Li et al., 2016). While 
this inflammatory response should result in elimination of Salmonella, the over-
activation during infection results in release of large amounts of bacteria capable of 
infecting naïve recruited cells. SipB is also able to induce apoptosis in a caspase-1 
independent manner involving activation of caspase-2, -3, -6, and -8 (Jesenberger et 
al., 2000). In addition to apoptosis and pyroptosis, Salmonella is also able to induce 
oncosis in macrophages (Sano et al., 2007). Oncosis is associated with macrophage 
swelling resulting in cell death, with Salmonella-induced oncosis characterized by F-
actin dissociation. Subsequently the flagellated Salmonella escapes from oncotic 
macrophages via flagellar movement (Sano et al., 2007). 
Although the methods presented here will effectively release intracellular cargo, the 
associated host cell death may significantly contribute to tissue damage and 
secondary inflammatory damage, which may further delay recovery of patients. While 
certainly an option to consider for further development, specifically where cell death 
and increased inflammation would not be as detrimental (e.g. cancerous tissue), a 
more optimal solution in scenarios where minimisation of inflammation – as well as the 
availability of functional macrophages - might be more critical, would be achieving 
release of drugs without the sacrifice of host cells. 
Manipulation of the host cell’s expulsion mechanics without killing the host has indeed 
been described for a few microbes, although much less information is available in this 
context. From the literature, it seems that only two egress methods have been 
described: direct spread into neighbouring cells and expulsion into the extracellular 
environment. As briefly eluded to earlier, L. monocytogenes escapes from the host 
phagosome into the cytosol through activity of pore forming LLO (Alberti-Segui et al., 
2007). However, complete escape from the host macrophage is aided by the effector 
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responsible for modulation of the host actin polymerisation machinery. Surface 
anchored actin assembly-inducing protein (ActA) interacts with the ARP2/3 complex 
to mediate actin polymerisation on the bacterial surface, which in turn creates sufficient 
force to induce membrane protrusion and cell-to-cell spread (Skoble et al., 2000). The 
actin-propelled bacteria creating these membrane protrusions induce uptake into 
neighbouring cells via a process called efferocytosis (Czuczman et al., 2014). Here, 
LLO damages the plasma membrane of protrusions, resulting in surface presentation 
of the inner membrane leaflet lipid, phosphatidylserine (PS) (Czuczman et al., 2014). 
The PS+ protrusions are recognised by the T cell immunoglobulin and mucin-domain 
containing protein 4 (TIM-4) on macrophages, which subsequently mediates the 
uptake of PS+ protrusions (Czuczman et al., 2014). The bacteria may also be present 
in PS+ vesicles, formed as a result of Ca2+ dependent membrane repair and scission 
of the initial PS+ protrusion (Czuczman et al., 2014). Both PS+ vesicles and 
protrusions are similarly taken up by neighbouring cells via TIM-4. Listeria are one of 
the few phagocytically internalised microorganisms that allow host cell survival after 
escape. Thus, the processes regarding expulsion of Listeria is of great interest as 
target for manipulation or adoption in therapeutic drug delivery systems. 
Chlamydia is also known to exit the host cell by extrusion, although it can also induce 
cell lysis (Hybiske et al., 2007). These methods exhibit almost identical prevalence but 
are markedly distinct and independent. The exact bacterial trigger facilitating either 
one or the other outcome has yet to be fully elucidated. Cell lysis is known to be 
protease and calcium dependant and entails perforation of the inclusion body 
(Chlamydia-containing vacuole) and plasma membrane (Hybiske et al., 2007). 
Chlamydia-infected host cell lysis has been suggested to be linked to microbe-
associated apoptotic cell death, although minimal direct evidence exists in support of 
this notion (Perfettini et al., 2003). Regardless, the extrusion capability of Chlamydia 
from host cells without cell lysis is of greater interest here. With this technique, 
inclusion body extrusion requires actin polymerisation, myosin II, RhoA and Neuronal 
Wiskott-Aldrich Syndrome Protein (N-WASP) (Hybiske et al., 2007). The formation of 
an actin coat around the inclusion is correlated to extrusion out of the host cell. Host- 
and bacterium-derived factors play a role in the formation of the actin coat. For 
example, in humans, host-derived septins (GTP-binding proteins) form structures 
around the inclusion and co-localize with F-actin, resulting in the formation of F-actin 
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fibres around the inclusion (Chin et al., 2012; Volceanov et al., 2014). This process 
facilitates normal extrusion of Chlamydia inclusions from host cells (Volceanov et al., 
2014). Actin stabilisation by jasplakinolide (actin polymerisation agent) alone was 
reported to induce extrusion, which substantiates the role of septins in extrusion 
(Hybiske et al., 2007). In terms of therapeutic application, this may suggest that the 
intervention achieved by Chlamydia on the host cell mechanics may be less 
detrimental to the host cell compared to other microbial exit strategies. In a therapeutic 
context, this may result in faster normalisation of function in the host cell, which is 
much desired, as these host cells may then be able to participate in the normal 
inflammatory process that would be required for clean up after the drug has fulfilled its 
function. 
Non-lytic release into the extracellular space has also been observed for Cryptococcus 
neoformans, albeit at low frequencies of 5-15% in vivo (Bojarczuk et al., 2016). 
Autophagy has been implicated in Cn intracellular lifestyle with components such as 
Atg-2a, -5, -9a, -12 and LC3 observed in close proximity to the Cn containing 
phagosome (Qin et al., 2011; Nicola et al., 2012). The effect of autophagy is dependent 
on opsonin, macrophage type and activation state (Nicola et al., 2012). Autophagy 
does seem to play a role in host defence against Cn, with disruptions in autophagy 
affecting host fungistatic activity and fungal growth (Qin et al., 2011; Nicola et al., 
2012). However, this is a double-edged sword with autophagy also seemingly playing 
a role in Cn release. This is evident by the observation of Atg-5-knockout clones of 
J774.16 and RAW264.7 cells having reduced incidence of non-lytic exocytosis events 
(Qin et al., 2011; Nicola et al., 2012). This, along with the observation of LC3 
surrounded cells outside macrophages, suggests a possible role of autophagy in non-
lytic release of Cn (Nicola et al., 2012). Therefore, while autophagy aids in the host 
defence against Cn, it also participates in the dissemination of Cn through non-lytic 
release. This eludes to a balance that must be maintained by the host regarding 
autophagy, with either decreased fungistatic activity combined with decreased non-
lytic release, or vice versa. In addition to the potential role of autophagy in the non-
lytic release of Cn, other factors can also play a role in this route of Cn dissemination. 
The increase in pH of the Cn-containing phagosome results in increased occurrence 
of non-lytic release. Artificially increasing phagosomal pH results in increased 
expulsion of Cn and when compared to the in vivo situation, the damage caused by 
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Cn to the phagosome could result in a similar pH increase (Nicola et al., 2011). 
Unfortunately, the Cn effectors responsible for non-lytic release have not yet been 
elucidated. However, in addition to the potential role of autophagy, the MAP 
extracellular receptor kinase 5 (ERK5) of host cells is implicated in the regulation of 
non-lytic release, with its inhibition resulting in increased release rates (Gilbert et al., 
2017). Furthermore, actin polymerisation also plays a role in release of Cn from the 
host (Johnston et al., 2010). In contrast to other pathogens such as Listeria and 
Chlamydia, actin polymerisation inhibits Cn release through actin flashes on the Cn 
containing phagosome (Johnston et al., 2010). Although some information regarding 
the non-lytic release of Cn is available, it remains poorly understood and the exact 
mechanism for this escape method is still elusive. 
The body of research investigating intracellular pathogens and their host-interacting 
mechanisms is significant. However, specific information on the microbial effectors is 
still largely lacking, probably owing to the fact that the main focus of research was the 
prevention of these microbial actions, rather than full elucidation thereof for 
implementation. In addition, effectors secreted by invading microbial forces exhibit a 
large degree of built in redundancy, so that it is not surprising that the task of identifying 
specific roles for specific effectors has remained largely unaccomplished. Specifically, 
in terms of microbial expulsion, information is largely lacking, with only a handful of 
known microbial effectors. Considering this, clearly a new approach is required. The 
recent advancements in gene editing, heterologous expression, live cell imaging and 
-omics technologies may provide a more powerful platform from which to investigate 
the complex host-pathogen interaction and the effectors involved, especially in the 
context of expulsion from immune cell hosts. 
2.4. The Impossible Made Possible? 
From our review of the literature, we propose that most of the limitations of current 
drug delivery systems can be overcome by harnessing microbial strategies. We 
hypothesize that the synthetic microbe drug delivery system we describe here would 
a) address poor drug-delivery to target tissue – especially at sites with low blood supply 
– b) increase treatment efficacy with lower treatment doses and thereby c) reduce 
adverse host reactions. A visual representation of the proposed system is provided in 
Figure 2.2. 
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In terms of the system we propose, we foresee two novel preparatory steps to be done 
in parallel. Firstly, monocytes should be isolated from peripheral blood collected from 
individuals with a requirement for drug delivery, to enable autologous re-infusion. 
These macrophages can then be propagated in culture, differentiating and polarizing 
them into M1 phenotype macrophages, as previously described (Mia et al., 2014), to 
achieve the phenotype known to be most capable of translocating out of circulation 
and into tissue (Arnold et al., 2007 a; Africa et al., 2015 a;  b). In order to prevent 
intracellular degradation, polarized macrophages can be treated to achieve transient 
phagosome maturation arrest, by in vitro exposure to arresting agents such as 
Wortmannin, Concanamycin A and Chloroquine, which we have previously 
successfully illustrated (Visser et al., 2018). The fact that phagosome maturation arrest 
is achieved by in vitro intervention is a strength of this model, as this eliminates patient 
exposure to these potentially harsh chemicals and their related adverse effects. 
Secondly, the drug should be packaged in multiple layers of nanoparticle coatings 
(Figure 2.2A). These layers will serve to protect the drug from degradation, and can 
be peeled away in sequential, controlled steps to achieve controlled expulsion and 
release of the drug after delivery at its required site. With advancements in polymer 
sciences, smart polymers can be designed that have effectors conjugated to the 
polymers and can also be developed for directed multiphasic release of effectors at 
certain checkpoints. (The nature of the different layers will be clarified in the discussion 
of the expulsion phase and illustrated in Figure 2.2). 
To construct the synthetic microbe drug delivery system, phagosome maturation 
arrested macrophages will engulf opsonized nanoparticle-enclosed drugs (the 
synthetic microbe) and form a phagosome containing this cargo (Figure 2.2). The 
number of synthetic microbes taken up per macrophage may be optimized by 
adjusting macrophage-microbe exposure time. Uptake is largely dependent on particle 
proximity to the macrophage as well as size and shape of particles (Beningo et al., 
2002; Champion et al., 2006; Underhill et al., 2012). Determining the exact onset of 
engulfment, following introduction of particles into cell media, is complex and may 
need optimization on a case-specific basis. Unpublished data from our group suggests 
initiation of engulfment to occur within 5 min, with particles included at a 1:4 ratio with 
cells. From the literature, the last stage of phagosome maturation (phagolysosome 
biogenesis) occurs around 1h after engulfment (Jahraus et al., 1998). Our 
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implementation of an arbitrary exposure time of one hour resulted in significant 4.5µm 
particle engulfment (>1 particle per cell, in ~70% of cells) by both arrested and 
untreated macrophages. Since macrophages are capable of repeated engulfment 
cycles (irrespective of arrest), carrier cells should be removed from drug-containing 
media and washed after the appropriate engulfment period, to prevent overloading of 
macrophages and potentially compromising their ability to traverse endothelial 
barriers, as well as eventual cell death (if particle load exceeds cytosol volume or steric 
hindrance causes membrane rupture during transmigration) (Champion et al., 2006; 
Visser et al., 2018). At this point, the drug-loaded macrophages are ready for 
autologous re-administration into the patient via infusion into the peripheral circulation 
(Figure 2.2B). 
As stated earlier, macrophage migration to sites for delivery will rely on the inherent 
macrophage capacity for chemotactic mobility. However, in vivo testing of the system 
will elucidate whether further optimization is required. Upon arrival at the site for 
delivery, controlled expulsion of the cargo and subsequent release of the drug will be 
achieved through multiple consequential steps. Specifically, the phagosome lysing 
and membrane escaping agents (i.e. microbial effectors) would be released upon 
arrival at target location. This can only be achieved after transient phagosome 
maturation has expired and phagolysosomal degradation agents activate this layer. 
This biphasic layer would, in turn, allow escape of cargo into the cytosol, as well as 
expulsion thereof into the extracellular environment through microbial effectors.  The 
substantial amount of genome data currently available should enable relatively 
comprehensive genomic data mining for novel and existing microbial effectors. The 
use of genome mining in this context will only be useful if information (e.g. homology 
regions, structural information) about effectors are available. The use of techniques 
such as proteomics along with bioinformatic mining/analysis has been suggested as 
more useful tools in combination to identify effectors (Na et al., 2015; Cheng et al., 
2017). For example, in recent studies, proteomics has been used to identify novel 
effectors in Salmonella. Although proteomics can be a useful tool in identification of 
effectors it is only the first step. Next would be to heterologously express the identified 
effectors. Several bacterial effectors have been expressed in heterologous systems 
with success (Skoble et al., 2000; Churchill et al., 2005; Weigele et al., 2017). Most 
notably, the Listeria effectors LLO and ActA have been recombinantly expressed, with 
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recombinant LLO also being used for the effective delivery of several compounds to 
the cytosol of cells (Lee et al., 1996; Skoble et al., 2000; Mandal et al., 2002; Provoda 
et al., 2003; Stier et al., 2005). The ability to identify and express possible effectors 
creates the opportunity to manipulate the host endocytic pathway. However, these 
effectors need to be protected from degradation and secreted in a sequential manner 
to effectively modulate host processes.  
In order to prevent asynchrony of final drug release and arrival of synthetic microbe at 
the target site (i.e. release of drug at inappropriate sites), an innocuous, bio-compatible 
layer, such as PNIPAAm (mentioned above), could be incorporated. This layer would 
be the inner most layer and protect the drug until controlled drug dissemination at the 
required site is achieved via external stimulus (e.g. temperature or ultrasound). In the 
case of a PNIPAAm layer, final drug dissemination can be achieved by temperature 
increase (Feng et al., 2014). In addition, microbubbles could also be incorporated as 
protective drug micelle, instead of PNIPAAm. These microbubbles would then be 
degraded by external ultrasound stimulation (Huang et al., 2015; Lv et al., 2016; Fan 
et al., 2018). This layer should ideally consist of non-biodegradable but bio-compatible 
constituents, to prevent drug release into circulation and exposure to off-target tissue. 
Furthermore, augmented host protection can be achieved by allowing the safe 
extrusion of intact drug-micelles through the urinary tract. 
The redundancy employed in the aforementioned approach is another characteristic 
we could adopt from the plethora of redundancy employed by microbes during immune 
evasion, in order to maximize control over drug delivery and minimize risk of undesired 
effects. 
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Figure 2.2: Visual representation of the proposed system. (A) Simultaneous preparation of the 
synthetic microbes (1) and autologous macrophages (2) are followed by introduction of the synthetic 
microbe into phagosome maturation arrested macrophages (3). The complete system can now be 
administered into circulation for in vivo delivery. (B) Intracellular events for in vitro engulfment of 
synthetic microbe (3), in vivo maintenance/expulsion (4–7) and final delivery of drug at target site (8–
9). 
 
2.5. Post-Delivery Clearance of the System 
Given the potential complication of polymer accumulation in vivo, or premature drug 
release, it is perhaps relevant to briefly discuss safety aspects of this system. The 
utilization of M1 macrophages would be advantageous as they would remain at target 
locations post-delivery and could potentially contribute to faster resolution of either 
primary inflammation (present due to the disease state) or secondary inflammation 
(required to clear bacterial debris after effective treatment). In support of this theory, 
the M1/M2 phenotype presents with some plasticity as tissue resident macrophages 
have been shown to change phenotype following appropriate effector exposure or 
systemic infection and activation by pathogens (Arnold et al., 2007 a; Mills, 2012).  
This low risk feature is the result of the non-lytic mechanisms employed to achieve 
expulsion, which is novel. 
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In terms of clearance of the components of the nanoparticle layers themselves, 
polymeric nanoparticles have demonstrated clearance rates of hours to several days 
(Alexis et al., 2008; Feng et al., 2014). Macrophages failing to reach their intended 
target sites may still release the encapsulated drug, but final dissemination of drugs at 
unintended sites is unlikely, due to the requirement for external stimulus. Thus, 
encapsulated drugs, polymeric debris and loaded macrophages should be efficiently 
cleared from the system, so that no long-term implications due to residual drugs or 
synthetic microbe components are expected.  
Clearly, a model proposing quite significant paradigm shifts, such as the one we 
described here, requires substantial in vitro and in vivo testing and optimization by 
multiple laboratories. Given the requirement for in vivo tracking of cells, a zebrafish 
model may be the ideal choice for pilot studies, as the basic anatomy of the fish 
facilitates leukocyte migration tracking (Langenau et al., 2004) and this model has 
been employed in the context of macrophage migration (Wang et al., 2016; Barros-
Becker et al., 2017).  Additionally, in vivo tracking can also be achieved by permanent 
intracellular cell labeling and/or lasing techniques (Schubert et al., 2015) that would 
elucidate the exact location of carrier macrophages as well as their cargo over an 
extended period.   
2.6. Conclusion 
Intracellular pathogens have developed a unique arsenal of tools to evade the immune 
system and thrive within host cells. The modulation of host processes, specifically 
modulation of the endocytic pathway, not only make these pathogens difficult to treat 
and dangerous, but also provides the opportunity to utilize and modify their methods 
for human gain. If the right combination of these effectors are repurposed, they can be 
used to develop a macrophage-based delivery system for the transport and controlled 
delivery of therapeutic agents packaged into a “synthetic microbe” as described here, 
to significant benefit of patients currently struggling with diseases at non-accessible 
sites or those caused by multi-drug resistant pathogens.  
The success of a host-derived or biological delivery system is dependent on a key 
understanding of how microbial effectors work and what combination would result in 
effective release without severe side-effects, keeping in mind that the effectors are 
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indeed potent virulence factors. Advancements in molecular biology, -omics, 
bioinformatics and live cell imaging have resulted in the identification of effectors and 
their roles in the host-microbe/pathogen interaction, using and building on this 
information, effectors can be chosen that would result in the desired outcome. Utilizing 
synthetic biology and heterologous expression, effectors can be produced and tailored 
for specific functions. Although some developmental steps for the proposed synthetic 
microbe drug delivery model remains to be addressed in more detail, we believe that 
rapid development in e.g. polymer design and the aforementioned advancements in 
techniques that are used to characterize and tailor effectors, can be used to overcome 
these limitations in the very near future.  
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We hypothesize that it is possible to employ microbial effectors - Listeria 
monocytogenes effectors LLO and ActA - to induce cargo expulsion from human 
carrier cells (primary M1 polarised macrophages) in the absence of infection, in a 
manner that would not result in lysis of carrier cells. Secondly, we hypothesise that it 
is possible to synthesise LLO and ActA in significant amounts using an E.coli 
heterologous GFP-linked protein expression system. 
2.8 . Aims and Objectives  
In order to test our hypothesis, we formulated the following aims and objectives:  
Aims: 
1. Developing an expression system to synthesise microbial effectors 
2. Using these effectors to induce expulsion from carrier cells 
Objectives: 
1. Synthesis of sufficient amounts of the chosen microbial effectors LLO and ActA 
2. Determining appropriate activity of synthesised effectors in vitro 
3. Determining expulsion of effector coated beads from carrier macrophages 
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Chapter 3: Methods 
3.1. Plasmid Design 
The Listeria monocytogenes effectors LLO and ActA, were translationally fused to 
green fluorescent protein (GFP) and expressed in Escherichia coli. Generation of a 
backbone plasmid containing mgfp5 (GFP gene) including an N-terminal 6x 
polyhistidine-tag (His tag) and C-terminal WELQut protease site was done according 
to previous reports (van Staden et al., 2019) (Figure 3.1, 3.2). Briefly, the mgfp5 gene 
was amplified from the pTRKH3-ermGFP using the primers listed in Table 3.1 and 
purified using the pJET PCR purification kit according to the manufacturer’s 
instructions (Thermo Fisher Scientific). The PCR product and pRSFDuet-1 were 
digested with the restriction enzymes BamHI/PstI. The digestion products were 
electrophoretically separated on an agarose gel and bands corresponding to the 
corrected sizes were excised and purified from the gel pieces using the ZymoClean 
gel DNA recovery kit according the manufacturer’s instructions (Zymo Research). The 
purified digestion products were ligated using T4 ligase according to the 
manufacturer’s instructions (New England Biolabs). The resulting pRSFGFP was used 
to transform chemically competent E. coli BL21 (DE3) cells. For transformation, the 
ligated plasmid DNA (pDNA) was added to competent cells (thawed on ice) and 
incubated, on ice, for 5 minutes. Cells were subsequently heat shocked at 37°C for 10 
min, after which warm (37˚C) Luria Bertani (LB) broth was added to a total volume of 
1 mL. Cells were recovered at 37°C for 1 hour and plated onto LB agar containing 50 
µg/mL kanamycin. Plates were incubated at 37°C until visible colonies were observed. 
Colonies were selected and used to inoculate 5 mL of LB broth and incubated with 
agitation at 37°C for 18 hours. Plasmid DNA was isolated from these cells using the 
Pure Yield plasmid isolation kit according to the manufacturer’s instructions 
(Promega). Listeriolysin-O was amplified from L. monocytogenes EDG-e genomic 
DNA (gDNA, isolated using the Zymogen fungal/bacterial gDNA Miniprep kit) using 
the primers listed in Table 3.1, with the forward primer designed to exclude the N-
terminal signal peptide (Figure 3.1). Digested (PstI/NotI) and purified LLO was cloned 
into pRSF-GFP on a PstI/NotI fragment using T4 ligase, resulting in the translational 
fusion of LLO to His tagged GFP (Table 3.1) The resulting pRSFGFP-LLO construct 
was transformed into chemically competent E. coli BL21 cells as described elsewhere. 
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Plasmid DNA was isolated from positive transformants and used in sequencing 
reactions (CAF Stellenbosch). Correct transformants were used in subsequent 
expression experiments. 
 
Figure 3.1:  GFP-LLO plasmid map and sequence. Plasmid map: pRSFDuet-1 with GFP fused to 
LLO. Relevant restriction sites and WELQut protease site are indicated. Sequence: GFP-LLO including 
relevant restriction sites and protease cleavage sites. GFP sequence is indicated in green and LLO 
sequence indicated in black. 
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Figure 3.2: GFP-ActA-GST plasmid map and sequence. Plasmid map: pRSFDuet-1 with N-terminal 
GFP fusion to ActA and C-terminal fusion to GST. Relevant restriction sites and WELQut is indicated. 
Sequence: GFP-ActA-GST including relevant restriction sites and protease cleavage sites WELQut 
and AVPR for thrombin). GFP sequence is indicated in green, ActA sequence indicated in blue and 
GST sequence indicated in purple. 
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Several plasmid constructs were generated for the expression of ActA (refer to 
Appendix 2), due to degradation products observed during the expression and 
purification of ActA. The final construct resulted in the translational fusion of ActA to 
His tagged GFP on its N-terminal and a glutathione S-transferase (GST) tag on the C-
terminal (Figure 3.2). Actin Assembly-Inducing Protein was amplified from L. 
monocytogenes EDG-e gDNA with the primers designed to exclude the N-terminal 
and C-terminal signal peptide and transmembrane domain, respectively (Figure 3.2, 
Table 3.1).  The GST tag was amplified from pET41a(+) using primers listed in Table 
3.1. Purified ActA PCR product was digested with PstI/NotI and ligated into pRSFGFP 
Table 3.1: Primers used in this study 
ID Primer Name Primer Sequence Description Ref
f 
1 GFP_BamHI_F GGATCCGATGAGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTC 











3 GST_NotI_F GCGCGGCCGCGTCCCCTATACTAGGTTATTGGAAA PCR of GST 
tag from 
pET41a (+) 
* 4 GST_XhoI_R CAGACTCGAGTTACGATTTTGGAGGATGGTCGCCA 




es EDGe gDNA 
* 6 LLO_NotI_R ATTATGCGGCCGCTTATTCGATTGGATTAT 
7 WActA_PstI_F GGGAACTGCAGGATAGCGAAGATTCTAGTCTAAACAC PCR of 
truncated 
ActA from L. 
monocytogen
es EDGe gDNA 
* 8 ActA_NotI_R ATGCGGCCGCTTACGTCGTATGGTTCCCTG 
9 mCherry_NotI_F 





















$ (van Staden et al., 2019). * This study. # Sequences obtained from Novagen 
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previously digested with PstI/NotI. The ligation product was transformed and purified 
as described elsewhere. The resulting pRSFGFP-ActA construct was subsequently 
digested with NotI/XhoI and used in a ligation reaction with the GST tag (digested with 
Notl/Xhol). The product from the ligation reaction was used to transform chemically 
competent E. coli BL21 (DE3) cells and pDNA isolated as described elsewhere. To 
further increase the stability of ActA during expression an E. coli BL21 (DE3) strain, 
ArcticExpress, harbouring the cold-adapted chaperonins Cpn10 and Cpn60 was 
employed. Transformation and culturing of ArcticExpress E. coli BL21 (DE3) is 
essentially performed as described for E. coli BL21 (DE3) with one exception. During 
culturing, gentamicin (20 µg/mL) is included in order to maintain the plasmid 
harbouring cpn10 and cpn60 (pACYC-based plasmid). 
3.2. Protein Synthesis and Purification 
The GFP-linked heterologous expression method used for purification of LLO and 
ActA allowed real time validation of purification products through visible GFP 
fluorescence in samples and SDS PAGE gels (Figure 3.3) (van Staden et al., 2019). 
3.2.1. Listeriolysin-O (LLO) 
Escherichia coli BL21 (DE3) cells expressing GFP-LLO were inoculated in 10 mL LB 
broth containing 50 µg/mL kanamycin and incubated overnight at 37°C under 
agitation. For thio-B-D-galactopyranoside (IPTG) optimization, the overnight culture 
was used to inoculate 200 mL Terrific Broth (TB; 1% v/v) containing 50 µg/mL 
kanamycin. Flasks were incubated at 30°C on a shaker until an optical density 
(OD600nm) of 0.6 was reached. Cells were induced with 0.25, 0.5 and 1.0 mM IPTG and 
expressed for 24 hours at 26°C with agitation. Cells were collected via centrifugation 
at 7500 rpm for 15 min at 10°C and wet weight recorded. The pellets were frozen 
before cells were lysed with lysis buffer (5 mL/g cell wet weight) for 30 min on ice. 
Lysis buffer was made up in Start Buffer (SB) containing 30 mM imidazole (SB30), 1 
mg/mL lysozyme, 1 U/mL RNAse (NEB) and 6 U/mL DNAse (NEB) and SigmaFast 
(EDTA free) protease inhibitors (Sigma-Aldrich; added according to manufacturer’s 
instructions). Cells were sonicated on ice three times at 70% power output, 90% 
pulses for 3 min and centrifuged at 13000 rpm for 45 min at 10°C to separate cell 
debris from GFP-LLO containing lysate. Prior to isolating protein via immobilized metal 
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affinity chromatography (IMAC), His Trap HP Ni-NTA His tag columns (1 mL, GE 
Healthcare) were equilibrated with 5 column volumes of SB30, followed by application 
of cell-free supernatant. Columns were washed with SB30 for 10 column volumes and 
GFP-LLO eluted using SB containing 500 mM imidazole over 5 column volumes. The 
eluted samples were desalted against PBS (pH 7.4) using 10 kDa spin columns 
(Thermo Fisher). Protein concentration for yield determination of desalted proteins 
were determined using the BCA protein assay according to the manufacturer’s 
instructions (Thermo Fisher).  
Desalted GFP-LLO concentration was adjusted to 1 mg/mL for determination of 
optimal cleavage conditions. Listeriolysin-O was liberated from its GFP fusion partner 
by cleavage with 0.5 U, 1.0 U, 5.0 U and 10 U WELQut protease for 16 hours at 26°C 
in a total reaction volume of 25 µL. Optimal WELQut concentration was evaluated by 
SDS-PAGE analysis. Using optimal cleavage conditions, LLO was further purified to 
remove the GFP fusion partner and WELQut protease (also His tagged). Imidazole 
was added to the cleavage reaction to a final concertation of 10 mM and applied to a 
His Trap HP Ni-NTA column previously equilibrated with 10 mM imidazole. The LLO 
containing flow through was collected, with His tagged-GFP and -WELQut protease 
remaining on the column. The purified LLO was desalted with PBS (pH 7.4) using 10 
kDa protein concentrators and used in subsequent experiments.    
3.2.2. Actin Assembly-Inducing Protein (ActA) 
Purification of GFP-ActA-GST was done in a similar manner to that of GFP-LLO with 
the exception of additional GST tag purification (Figures 3.3). Escherichia coli BL21 
(DE3) ArcticExpress cells expressing GFP-ActA-GST were inoculated in 10mL LB 
broth containing 50 µg/mL kanamycin and 20 µg/mL gentamycin and incubated 
overnight at 30°C under agitation. The overnight culture was used to inoculate 500mL 
TB (2 % v/v) containing 50 µg/mL kanamycin and 20 µg/mL gentamycin. Flasks were 
incubated at 30°C on a shaker until an OD600nm of 0.5 was reached. Cells were 
subsequently induced with 0.5 mM IPTG and allowed to express at 26°C with agitation 
for 18 hours. After expression cells were collected via centrifugation at 7500 rpm for 
15 min at 10°C and wet weight recorded. The pellets were frozen before cells were 
lysed with 5 mL/g wet weight lysis buffer for 30 min on ice. Lysis buffer was made up 
in SB containing 20 mM imidazole, 1 mg/mL lysozyme, 1 U/mL RNAse (NEB) and 6 
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U/mL DNAse (NEB) and protease inhibitors (Sigma-Aldrich). Cells were sonicated on 
ice three times at 70% power output, 90% pulses for 3 min, centrifuged at 13000 rpm 
for 45 min at 10°C. All subsequent purification steps were done on ice to reduce 
degradation of GFP-ActA-GST. Prior to isolating protein via IMAC, His Trap HP Ni-
NTA His tag columns (1 mL, GE Healthcare) were equilibrated with 5 column volumes 
of SB containing 20 mM imidazole (SB20) supplemented with protease inhibitors (1x 
stock made up according to manufacturer’s instructions), followed by application of 
cell-free supernatant. Columns were first washed with SB20 containing protease 
inhibitors for 10 column volumes. Columns were further washed with PBS containing 
20mM imidazole (PBS20) for 10 column volumes before eluting GFP-ActA-GST with 
PBS containing 125 mM imidazole. The eluent was diluted 1:1 in PBS (pH 7.4) and 
dithiothreitol (DTT) was added to a final concentration of 5 mM. The diluted eluent was 
applied to a column packed with glutathione agarose (2 mL; Thermo Fisher) and 
allowed to bind with continuous circulation for 1 hour to allow adequate binding of 
GST-tagged protein. Columns were washed with 10 column volumes of PBS (pH 7.4) 
and bound GFP-ActA-GST eluted from the column with PBS containing 10 mM 
reduced glutathione (pH 8).  
 
 
Figure 3.3: Schematic of Protein Purification: Immobilized metal affinity chromatography (IMAC; 
steps 1-4) and glutathione S-transferase (GST; steps 1-7) purification used in this study. Image created 
in BioRender. 
 
Liberation of ActA-GST from the GFP fusion partner was achieved through cleavage 
with WELQut protease. The eluent from GST-tag purification was cleaved with 10 U 
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WELQut protease per millilitre of eluent and incubated for 16 hours at 8°C. After 
cleavage, imidazole was added to the reaction to a final concentration of 10 mM and 
applied to a His Trap HP Ni-NTA column pre-equilibrated with 10 mM imidazole. The 
flow through containing the liberated ActA-GST was collected and desalted in a 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (20 mM HEPES, 50 
mM KCl; pH 7.5) using a 10 kDa protein concentrator. Desalted samples were used in 
subsequent experiments and for determination of protein yield (protein concentration 
determined using BCA protein assay). Samples were collected throughout purification 
and cleavage reactions for analysis by SDS-PAGE.    
3.3. SDS-PAGE 
Samples were electrophoretically separated using tricine SDS-PAGE (Schägger, 
2006). Briefly, samples were added to tricine sample buffer (1:1) and incubated at 
37°C for 30 min. Subsequently, 7 µL sample was loaded into the wells of a 10% tricine 
SDS-PAGE gel. After separation GFP fluorescence was visualized using either a 
MiniBIS Pro DNR Bio-imaging system (DNR Bio-imaging systems, Israel) or Dark 
Reader DR195M Transilluminator (Integrated Scientific Solutions) (van Staden et al., 
2019). Gels were fixed with 25% Isopropanol and 10% acetic acid fixing buffer and 
stained using blue silver Coomassie stain until protein bands could be visualized 
(Candiano et al., 2004). 
3.4. Processing Donor Peripheral Blood Samples  
Ethical clearance exemption was obtained from Subcommittee C Human Research 
Ethics Committee (HREC) of Stellenbosch University (Reference # X15/05/013) for 
isolation of primary human monocytes and erythrocytes from donor blood. Monocyte 
isolation, differentiation and polarization into M1 macrophages was performed as 
previously described (Visser et al., 2018). Briefly, collected donor buffy coats from the 
Western Province Blood Transfusion Service was mixed at a 2:1 ratio with RPMI in 
order to facilitate layering onto a Histopaque gradient. This was centrifuged at 400 x g 
for 30 min after being washed in PBS containing 1 mM EDTA. The PBMC sample was 
then layered onto a 46% iso-osmotic Percoll solution containing PBS, RPMI and FBS 
before being centrifuged at 550 x g for 30 min. The monocyte layer was removed and 
plated onto 35 mm culture dishes and cultured for a total of 6 days in RPMI containing 
Stellenbosch University https://scholar.sun.ac.za




10% Human Serum, 100 U/mL Penicillin-Streptomycin, 2 mM Glutamax and 50 ng/ml 
GM-CSF. To induce polarisation into M1 phenotype 50 ng/ml LPS and 20 ng/ml IFN-
γ was added at 5 days into culture. Cells were harvested or imaged on day 6.  
3.5. pH-Dependant Protein Activity 
Haemolytic activity of LLO and GFP-LLO was determined at varying concentrations 
and pH, using human erythrocytes prepared from donated whole blood. The different 
pH levels were chosen to determine appropriate LLO activity, which is reported to 
occur from pH 6 and lower (Alberti-Segui et al., 2007). At physiologically relevant 
concentrations, LLO should have no haemolytic capacity at physiological pH of 7.4. 
Activity of LLO at lower pH levels is also in accordance with its pore forming activity 
within mature phagolysosomes (Friedrich et al., 2012). Furthermore, the concentration 
was chosen at 10x serial dilutions of the maximum protein yield obtained. This was 
conducted due to the lack of literature on the exact concentration of LLO haemolysis. 
Peripheral blood was centrifuged at 400 x g for 10 min and plasma removed. 
Erythrocytes were washed in PBS (pH 7.4) followed by centrifugation. Supernatant 
was removed and erythrocytes resuspended to original volume followed by dilution at 
1:50 in PBS at pH 7.4, 6.0 or 5.5 before 190 µL of these dilutions were loaded into 
wells of a 96-well plate and mixed with 10 µL LLO or GFP-LLO at varying 
concentrations. A positive control of 0.1% Triton X100 was included to induce 
complete lysis of erythrocytes in a separate reaction. An untreated sample and blank 
were also included. Plates were incubated at 37°C for 1 hour after which absorbance 
readings  were measured at 540 nm. Zero (blank) and 100% haemolysis was 
determined using PBS (pH 7.4, 6.0 and 5.5) and 0.1% Triton X100, respectively. All 
other groups were expressed as a percentage of the positive control, as previously 
described (van Staden et al., 2012). 
3.6. Microbial Effector Coating onto Carboxylate Modified Beads 
For in vitro testing with primary macrophages, the microbial effectors were coated onto 
200 nm carboxylate modified crimson polystyrene beads (Thermo Fisher; F8806). 
Bead stock (3.4x1012 beads/mL) was diluted into 100 µL 2-(N-
morpholino)ethanesulfonic acid (MES) buffer (50mM, pH 5.2) to a final concentration 
of 3.4x1011 beads/mL and incubated for 1 hour at 23°C. Beads were collected by 
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centrifugation at 10 000 rpm for 10 min at 23°C. The supernatant was removed and 
100 µL LLO (470 µg/mL) and 100 µL ActA (450 µg/mL) were added to the bead 
solution and incubated at 23°C for 4 hours. Beads were then washed three times with 
PBS before adding 100 µL O+ donor serum.  
Effective bead coating was evaluated using SDS-PAGE, samples were collected of 
stock LLO, ActA and LLO/ActA mixture before coating as well as supernatant after 
coating. Gels were analysed using ImageJ software (1.52a) to determine intensities of 
bands. The LLO and ActA (intact) stock bands were used to determine purity of 
respective effectors added to beads. In order to estimate bead coating the intensities 
of bands corresponding to LLO or ActA (intact) originally added to beads was 
subtracted from that remaining in the supernatant after coating. 
3.7. Confocal Microscopy for Actin Polymerisation Activity 
Sodium citrate (3.2%) vacutainers were used to isolate donor peripheral blood. Blood 
was centrifuged at 1500 x g for 10 min at 4˚C, supernatant was removed and washed 
with PBS. After washing, 2.16x1010 cells were lysed in 2x lysis buffer (2 M Tris-HCl, 
pH 7.0, 1.2 M KCl, 2 mM DTT, 1 mM MgCl2, 2 mg/mL Tween-20, 7.5% (w/v) Triton 
X100, and 0.2 mM protease inhibitors) for 30 min at 23˚C (modified from Schafer et 
al., 1998). Buffer was removed by centrifugation at 10 000 RPM for 10 min at 23˚C. 
Lysate was resuspended in ddH2O and transferred to a protein concentrator tube. 
Lysate was centrifuged 3 times at 4000 x g for 30min to desalt the sample, after which 
it was resuspended in PBS and centrifuged again. This reduced the Tris-HCl 
concentration to 0.013M. Additional 0.2 mM protease inhibitors were added. Lysated 
RBCs were labelled with Oregon Green Phalloidin at 0.5 µL/mL (0.5x working 
concentration) and exposed to ActA coated beads (ActABeads) at 6.8x108 beads/mL. 
In order to facilitate actin polymerisation, free ATP was added at 2 µL/mL of 10x assay 
buffer (500 mM Tris-HCl, 100 mM MgCl2, 10 mM ATP, 100 mM DTT, pH 7.5). Lysates 
were loaded into an 8-chamber slide and imaged at 100x magnification using a Carl 
Zeiss LSM780 confocal microscope with ELYRA S.1 super resolution platform (Carl 








3.8. Confocal Microscopy of Fixed Actin Polymerisation 
Isolated human macrophages (1x106 cells/mL) were treated with 3.4x108 beads 
coated with LLO and ActA (LLOActABeads) and incubated at 37˚C with 5% CO2 under 
80% humidity 1 hour and 2 hours, respectively, before being fixed with 4% 
paraformaldehyde for 10 min. Fixed cells were labelled with 1 µL/mL (1x) Oregon 
Green Phalloidin to determine actin polymerisation. Cells were imaged using a Carl 
Zeiss LSM780 confocal microscope (Carl Zeiss, Germany) and analysed with ZEN 
black edition imaging software. This pilot study was done to test ActA activity prior to 
higher throughput assessment using imaging flow cytometry.   
3.9. Live Cell Imaging of Listeria monocytogenes 
Listeria monocytogenes EDG-e was inoculated in 10 mL Brain heart infusion broth 
overnight. An aliquot of the overnight culture (1 mL) was centrifuged at 10 000 rpm 
and cells washed three times with PBS (pH 7.4). After wash steps cells were 
resuspended in 1 mL PBS (pH 7.4), resulting in a concentration of ~ 3.9 x 109 CFU/mL. 
Listeria monocytogenes EDG-e were added to macrophages at a concentration of 
6.83 x 106 CFU/150µL culture media (multiplicity of infection > 22). 
Time lapse videos of infected macrophages were taken on a Carl Zeiss LSM780 
confocal microscope (Carl Zeiss, Germany) with ZEN black edition imaging software 
at 100x magnification. 
3.10. Bead Expulsion Assay using Imaging Flow Cytometry 
The AMNIS imaging flow cytometer has the unique ability of analysing samples at high 
throughput while simultaneously taking an image of every event, producing a highly 
reliable quantitative as well as qualitative results. Different methods of lifting 
macrophages from culture surfaces were tested to determine optimal conditions in 
terms of cell survival and immunocytochemistry fluorophore preservation prior to 
analysis via imaging flow cytometry (Appendix 3). The optimal detachment method of 
‘23°C Accutase Fix’ is described here. In order to assess time dependant expulsion of 
beads, macrophage populations were exposed to either 6.8x108 LLOActABeads or 
serum coated beads (SerumBeads). These cells were then incubated at 37°C with 5% 
CO2 under 80% humidity in separate 35 mm tissue culture dishes (Bio-Smart 
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Scientific; 20035) for each time point. Culture dishes were removed from incubation 
from the 15 min time point at 10 min intervals up to 75 min, media was aspirated and 
replaced with 1 mL 23°C Accutase. Dishes were then incubated at 23°C for 10 min 
before adding an additional 1 mL 23°C Accutase and incubating for another 10 min. 
Cells were carefully scraped using a cell scraper and transferred to 15 mL tubes for 
centrifugation at 400 x g for 10 min at 23°C in a swinging bucket centrifuge. 
Supernatant was discarded and pellet resuspended in 200 µL BD 
Fixation/Permeabilization solution (BD Biosciences; 554714) containing Hoechst 
(Sigma-Aldrich; 33342) and Oregon Green 488 Phalloidin at 5 µL/mL (0.5x) and 0.25 
µL/mL (0.25x), respectively. Cells were then incubated at 4°C for 20 min to allow for 
fixing, permeabilization and staining before centrifugation at 400 x g for 10 min at 23°C. 
Supernatant was discarded and the stained cell pellet was resuspended in 50 µL BD 
Perm/Wash solution (BD Biosciences; 554714) before being analysed on the 
ImageStream Mark II AMNIS imaging flow cytometer (Millipore Sigma, United 
Kingdom) using IDEAS acquisition software (version 6.2). Appropriate gates were 
drawn on the Aspect Ratio vs. Area graph to exclude debris, and the autosampler was 
set to record and count 10 000 events in the cell gate per sample. Illumination settings 
were set at 40 mW for 405 nm laser (Hoechst: nuclei), 100 mW for 488 nm (Oregon 
green phalloidin: actin) and 75 mW for the 642 nm laser (Crimson red: beads). 
Magnification was set at 60x with EDF (Extended Depth of Field) selected and 
instrument set to highest sensitivity with lowest speed. A spot count analysis was set 
up to determine intracellular bead count. After applying the previously determined 
focussed cells and single cells, the truth populations were chosen. Cells were 
organised according to Intensity MC Channel11 (bead channel). Low truth populations 
were chosen by selecting cells containing 0-1 bead and high truth populations were 
chosen from cells containing the highest number of beads in this channel. A total of 
50 cells were chosen for each truth population. To determine the average amount of 
beads/cell, the cumulative number of beads present in all bead-containing cells were 
averaged according to the number of cells in the sample for each time point. To 
determine the number of phagocytically active cells, the percentage cells of the total 
cell population containing 1 or more beads was recorded. 
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3.11. Statistical Analysis 
All statistical analysis was done using Graph Pad Prism 5. All data are presented as 
means ± SEM. Linear regression and ANOVA with Bonferroni host-hoc tests were 
conducted where appropriate. A p-value of < 0.05 was considered statistically 
significant. 
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Chapter 4: Results 
4.1. Heterologous Expression and Yield of LLO and ActA GFP 
Fusions 
Recombinant GFP-LLO and GFP-ActA-GST were successfully expressed in E. coli 
and expression/purification were validated using SDS-PAGE analysis. SDS-PAGE 
analysis indicated fluorescent protein products corresponding to a size slightly lower 
than that of LLO fused to GFP (~85 kDa; Figure 4.1). This is due to the samples not 
being boiled, which is important to maintain GFP fluorescence, causing GFP-LLO to 
migrate faster through the gel (Appendix 4). Liberation of LLO from its GFP fusion 
partner was achieved using the WELQut protease with amino acid recognition 
sequence W-E-L-Q-↓-X. Cleavage with WELQut was performed at several 
concentrations and as expected, liberated LLO increased with protease concentration, 
with 0.4 U/µg resulting in the best cleavage (Figure 4.2). Both GFP and WELQut 
protease contain His-tag sequences, making it possible to remove them through 
IMAC. Using this method LLO was separated from its fusion partner and from the 
protease (Figure 4.3). Liberated LLO corresponded to the correct size of ~56 kDa 
when separated using SDS-PAGE (Figure 4.4). The purity of LLO after purification 
was satisfactory with a single band observed after separation with SDS-PAGE 
(Figures 4.3, 4.4).  
 
Figure 4.1: SDS-PAGE of heterologously expressed GFP-LLO. Left: Stained gel, Right: 
Fluorescent image of GFP-LLO. L: Ladder (NEB ladder #P7712), 1: GFP-LLO eluted from IMAC column 
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Figure 4.2: SDS-PAGE of GFP-LLO cleavage. Left: Stained gel, Right: Fluorescent image of GFP-
LLO and GFP. L: Ladder (NEB ladder #P7712), 1: GFP-LLO (1 mg/mL), 2-5: GFP-LLO cleaved with 
WELQut protease at 0.02 U/µg, 0.04 U/µg, 0.2 U/µg 0.4 U/µg, respectively. A: GFP-LLO, B: LLO, C: 





Figure 4.3: SDS-PAGE of GFP-LLO cleavage and IMAC purification. Left: Stained gel, Right: 
Fluorescent image of GFP-LLO and LLO. L: Ladder (NEB ladder #P7712), 1: Uncut GFP-LLO, 2-7: 
Flow through from IMAC purification using increasing concentrations of imidazole, 10 mM, 20 mM, 30 
mM, 40 mM, 50 mM and 500 mM, respectively. A: GFP-LLO, B: LLO, C: GFP, D: WELQut protease. 
Cleavage reaction adjusted to final imidazole concentration of 10 mM before loading onto gel 
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Figure 4.4: SDS-PAGE of purified GFP-LLO and LLO used in erythrocyte lysis assay. Left: 
Stained gel, Right: Fluorescent image of GFP-LLO and GFP. L: Ladder (NEB ladder #P7712), 1: Uncut 
GFP-LLO, 2: Cleaved, IMAC purified and desalted LLO. A: GFP-LLO, B: LLO. 
 
Purification of ActA proved to be more challenging due to degradation during 
expression and purification and required some optimisation (Appendix 2). In order to 
increase yields of intact ActA a dual purification method was used. In order to use two 
affinity chromatography methods His tagged GFP and GST was fused to the N- and 
C-terminals of ActA, respectively. From SDS-PAGE analysis, clear degradation can 
be seen in samples collected from the first IMAC purification steps (in red frames 
Figure 4.5). The second purification step, utilizing the GST-tag (and glutathione 
agarose), yielded a pure product with little to no degradation (lane 5 of Figure 4.5). It 
should be noted that ActA has been shown to have aberrant migration when 
separating with SDS-PAGE, this is most likely due to its high proline content (Noireaux 
et al., 2000). To liberate ActA-GST from its fusion partner the same protease employed 
for GFP-LLO was used. After cleavage of GFP-ActA-GST a clear drop in the band 
(and fluorescence) corresponding to GFP could be observed along with the liberation 
of ActA-GST (lane 6 of Figure 4.5). Additional bands were observed after desalting 
and concentrating steps and possible degradation of the ActA product during the 16 
hours cleavage step can be observed (Figure 4.5). The purity of ActA-GST after 
affinity chromatography and desalting/concentration was also satisfactory (lane 8 of 
Figure 4.5). 
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Figure 4.5: SDS-PAGE of GFP-ActA-GST purification. Left: Stained gel, Right: Fluorescent image 
of GFP-ActA-GST and GFP. L: Ladder (PageRuler #26632), 1: IMAC flow through, 2: IMAC elution 
containing GFP-ActA-GST, 3: Dilution of IMAC elution before GST purification, 4: Flow through from 
GST column, 5: Elution from GST column containing GFP-ActA-GST, 6: WELQut protease cleavage of 
GFP-ActA-GST eluted from GST column, 7: Flow through from IMAC column containing ActA-GST after 
WELQut digestion, 8: Desalted and concentrated ActA-GST obtained from IMAC flow through. A: GFP-
ActA-GST, B: ActA-GST, C: GFP. Degradation products are outlined in red. 
 
Optimal GFP-LLO yields where obtained when expression was induced with 0.5 mM 
IPTG resulting in a GFP-LLO concentration of 109.01 mg/L and LLO concentration 
(after cleavage and purification) of 51.48 mg/L. Degradation of GFP-ActA-GST during 
expression and purification (Figure 4.5) resulted in a lower yield compared to GFP-
LLO with a final yield of ActA-GST of 890.35 µg/L.  
4.2. Microbial Effector Activity 
4.2.1. Haemolytic Activity of GFP-LLO and LLO 
The activity of purified GFP-LLO and LLO was determined in terms of its capacity for 
haemolysis of human donor erythrocytes (Figure 4.4 and 4.6). Potent LLO haemolytic 
activity was observed at pH 6.0 and 5.5, with LLO concentrations as low as 0.043 
ng/200µL (0.215ng/mL) resulting in haemolysis (13.03 % ± 0.4561), whereas 
significant reductions in haemolysis is observed at higher pH (pH 6.0: 4.026% ± 0.4478 
and no relative haemolysis at pH 7.4; Figure 4.6). This trend is also seen at 
0.43ng/200µL (2.15ng/mL) LLO where a pH of 7.4 (0.2110% ± 0.06090) resulted in 
significantly less haemolysis when compared to pH 6.0 and 5.5 (pH 6.0: 41.63% ± 
0.8381 and pH 5.5: 63.01% ± 0.6482). Thus, purified LLO had potent activity by 
inducing haemolysis especially at pH levels below that of physiological pH 7.4. Higher 
concentrations seemed to have saturated the sample to overburden pH dependency, 
subsequently inducing complete haemolysis at all pH levels including pH 7.4 (Figure 
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4.6). Of note, an upward trend in haemolysis from pH 7.4 to 5.5 is still observed, 
indicating that pH levels still play some role at higher concentrations. A two-way 
ANOVA of the data presented in Figures 4.6 and 4.7 was conducted to determine the 
effect of dose as well as pH.  
 
Figure 4.6: Erythrocyte haemolysis following LLO exposure at varying pH. Relative haemoglobin 
absorbance was collected at 540 nm, values expressed as percentage of positive control, mean ± SEM 
(n=3). Analysis via Two-way ANOVA. Brackets indicate p < 0.05. * = p < 0.05 vs Untreated. 
 
The activity of GFP bound LLO was also determined (Figure 4.7). The GFP-LLO 
haemolytic activity was significantly active below physiological pH at concentrations of 

























































Figure 4.7). Similar to LLO, haemolytic activity increased with increasing GFP-LLO 
concentration with haemolytic activity observed at pH 7.4 when GFP-LLO 
concentration is increased to and above 12.5ng/200µL (62.5ng/mL; 52.51% ± 1.206)  
 
Figure 4.7: Erythrocyte haemolysis following GFP-LLO exposure at varying pH. Relative 
haemoglobin absorbance was collected at 540 nm, values expressed as percentage of positive control, 
mean ± SEM (n=3). Analysis via Two-way ANOVA. Brackets indicate p < 0.05. * = p < 0.05 vs Untreated. 
 
4.2.2. Bead Coating 
The approximate concentration of the LLO and ActA-GST (intact) coating was 
































































(Figure 4.8). Indicating ~0.62 ng LLO with ~0.33 ng ActA coated onto each 0.2 µm 
bead.  
 
Figure 4.8: SDS-PAGE of LLO and ActA before and after coating onto beads. L: Ladder (Biorad 
#1610363), 1: ActA stock, 2: LLO stock, 3: Mixed LLO and ActA stock, 4: Supernatant of mixed LLO 
and ActA stock after coating (residual LLO and ActA left over after coating). A: ActA, B: LLO. 
 
4.2.3. Actin Polymerisation Activity of ActA 
The ability of ActA to polymerise actin was assessed by exposing erythrocyte lysates 
to polystyrene beads coated with ActA (ActABeads). Figure 4.9 shows actin 
polymerisation ‘clouds’ (white arrows) occurring in response to ActA. These clouds 
seem to start forming at 60 min post introduction of beads and tether beads to one 
another. This is apparent when considering the absence of these ‘clouds’ during 
SerumBeads exposure at the same time point. Some background polymerisation is 
observed. 
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Figure 4.9: Actin polymerisation induced by exposure to ActABeads. Panels indicate marked actin 
polymerisation ‘clouds’ when exposed to 1x (45.00µg), 0.5x (22.50µg) and 0.25x (11.25µg) ActABeads 
(white arrows), compared to SerumBeads control at the same time point. All frames indicate 
polymerisation at 70 min after introduction of beads. 
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4.2.4. In Vitro Validation of Actin Polymerisation 
The macrophages shown in Figure 4.10 were exposed to live L. monocytogenes and 
allowed to infect cells for 3 hours. Live cell time lapse images were collected with 
phase contrast to determine analysis time points for later LLOActABeads infection. 
From 2 hours post infection the cells showed actin polymerisation (white arrows), 
induced by L. monocytogenes infection. When comparing this to a different cell 
population at ~5 min post infection, no such actin polymerisation is observed, rather 
extension of pseudopodia is seen. Importantly, the phenomenon of membranous actin 
polymerisation is also seen when cells are exposed to synthesised effectors (Figure 
4.11), supporting induction of similar cellular processes when exposed to our synthetic 
microbe coated beads. Previous reports have shown these membrane actin spikes 
(Ishida et al., 2019), however, those present are significantly more in comparison. 
Additionally, marked cell shrinkage can be observed at 3 hours post infection, likely a 
process related to expulsion and intracellular pathogen load. (One limitation of this 
experiment was the inability to visualise L. monocytogenes associated actin comets. 
This is due to the inability of labelling live cells with the phalloidin actin stain. A pilot 
study was launched to determine possible phagocytosis of the label (Appendix 5), 
however, the stain remained within phagosomes, isolated from cytosolic actin 
filaments.)   
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Figure 4.10: Morphological changes during L. monocytogenes infection. Representative phase 
contrast images show actin polarisation of a primary human M1 macrophage, as evidenced  by 
membranous “spikes” protruding from the macrophage membrane (white arrows).  
 
Actin polymerisation induced by LLOActABeads was also confirmed in vitro using 
confocal microscopy (Figure 4.11). After two hours of exposure to LLOActABeads, 
human primary M1 macrophages exhibited greater actin polymerisation and 
membrane extensions or ‘spikes’ (white arrows) compared to cells at 1-hour, as well 
as previous reports of homeostatic membrane ‘spikes’ (Ishida et al., 2019). This is 
apparent when considering that only membrane extrusions, likely associated with cell 
movement, is observed in the SerumBeads control group. No rigid actin spikes can be 
seen protruding from membranes at either 1-hour or 2-hour time points during 
SerumBeads infection. These findings were satisfactory to progress this protocol into 

















Figure 4.11: Confocal microscope assessment of actin polymerisation. Images of separate cell 
populations exposed to SerumBeads and LLOActABeads, indicating extent of actin polymerisation 
(white arrows) at two time points. 
 
4.3. Cargo Expulsion: Quantitative Data  
Representative images of morphological changes in cells undergoing different 
engulfment and expulsion phases are presented in Figure 4.12. Bead count and 
localisation is observed as well as pseudopodia (blue arrows) and actin polymerisation 
(“membrane spikes”) (white arrows). Pseudopodia protrude from macrophages under 
both SerumBeads and LLOActABeads conditions at the 15 min time point, indicating 
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that engulfment is initiated in similar time frames while the coated effectors has not yet 
been activated (rows A and E of Figure 4.12). Accumulation of beads inside 
macrophages over time was observed in cells exposed to SerumBeads, but not those 
exposed to LLOActABeads (rows A-D and rows E-H of Figure 4.12, respectively). 
Almost all cells produced membrane spikes when exposed to LLOActABeads (rows 
F-H of Figure 4.12). This was particularly pronounced at 75 min and suggests that 
expulsion of beads through these spikes had occurred (Figure 4.12). Of interest, when 
considering the location of beads still inside host macrophages (Figure 4.13), 
SerumBeads seemed to be homogenously distributed throughout cells whereas 
LLOActABeads tend to localise toward the periphery. This could potentially be linked 
to the occurrence of actin polymerisation and should be quantitatively evaluated as an 
additional marker indicative of bead expulsion efficacy. 
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Figure 4.12: Phagocytic phases under control and effector treated conditions over time. 
Macrophage populations were exposed to SerumBeads or LLOActABeads for different time periods. 
Blue arrows: pseudopodia. White arrows: actin membrane spikes. Accumulation of beads is seen 
under SerumBeads exposure. BF1: first bright-field channel. 
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Figure 4.13: Intracellular bead location at 75min post infection. Representative images of 
macrophages at the same time point suggest a tendency for bead distribution predominating at the 
periphery of cells during LLOActABeads exposure.  
 
Most significant in terms of the current aim, was the intracellular accumulation of 
SerumBeads in macrophages over time, while  a significantly smaller accumulation of 









Figure 4.14: Number of beads per cell during exposure to SerumBeads and LLOActABeads. 
Average number of beads per cell given for effector treated (LLOActABeads) and control (SerumBeads) 
over time. Data points are means and error bars indicate SEM. Statistics: #, ANOVA main effect of 
treatment, p < 0.01. 
 
In addition, the percentage of cells containing intracellular beads (i.e. cells actively 
participating in phagocytosis) remained similar for the two treatment conditions 
(Figure 4.15). No significant inhibitory effect of effector coating on cellular bead uptake 
was observed (Figure 4.15). Furthermore, our pilot data showed satisfactory 
engulfment of 4 µm beads when coated with LLO (Appendix 6). Additionally, both 
conditions had a near identical bead/cell average at the 15min time point (Figure 
4.14), further hinting that exposure to effectors does not have an inhibitory effect on 
cellular bead uptake. Together, this suggests that the reduced number of beads seen 
under LLOActABeads exposure can only be attributed to a progressive loss or 
expulsion of beads from cells (Figure 4.14).     
 

























Figure 4.15: Percentage of cells actively participating in phagocytosis during SerumBeads and 
LLOActABeads exposure. Percentage of bead containing cells per population over time, indicate a 
similar number of cells during both conditions. Data points are means and error bars indicate SEM. 
Statistics: ANOVA main effect of treatment, p = 0.75. 





























Chapter 5: Discussion 
The majority of research focused on host-microbe interaction to date has been aimed 
at prevention of microbial infection or dissemination through identifying the active 
effectors or characterizing the redundant signalling pathways involved (Proal et al., 
2017; Ireton et al., 2018). In contrast, with this project we set out to identify functionality 
and utilisation of microbial effectors for therapeutic outcome. This builds on our 
previous work where ingestion and intracellular preservation of cargo has been 
achieved, while maintaining the transmembrane migratory capacity of carrier cells 
(Visser et al., 2018). In a paradigm-shifting approach, we decided to re-use this 
knowledge of microbes in a novel manner: our approach was to engineer a system 
that would promote dissemination of beneficial components/compounds rather than 
microbes themselves. In particular, we proposed to facilitate release of therapeutic 
cargo from carrier cells through the activity of specific microbial effectors and their 
manipulation of the host cell signalling pathways involved in expulsion mechanisms. 
Our previous work utilised microbial metabolites in a similar manner to induce 
phagosome maturation arrest and subsequent preservation of ingested cargo (Visser 
et al., 2018). Maturation arrest is however only transiently induced (with these 
metabolites and other compounds) allowing a period in which macrophages can move 
toward the target area before maturation arrest is lost and expulsion initiated. In this 
regard non-lytic release is advantageous as deposition of additional M1 type carrier 
macrophages into target areas would facilitate resolution of infection/inflammation 
(Abbas et al., 2014). In order to achieve our initial aim of  identifying adequate microbial 
effectors, the current literature needed to be evaluated in terms of the efficacy of 
inducing expulsion from carrier cells. Adequate knowledge of known expulsion-
inducing effectors with their signalling pathways and the possibility to obtain these 
effectors for experimental testing also needed to be addressed (Chapter 2). Following 
identification, focus was placed on how effectors could be synthesised, validated for 
purity and activity and tested in vitro. The subsequent sections will discuss how our 
methodological approach, and the results obtained, aided in the development of a cell-








5.1. Microbial Effector Identification 
An important hallmark for effector identification was non-lytic release of cargo from 
carrier cells. As mentioned elsewhere, this would deposit additional functional M1 
macrophages to the target site. Due to macrophage plasticity (Mosser et al., 2008) 
these cells could then shift toward a M2 phenotype and contribute to resolution of 
inflammation/damage. Therefore, focus was initially placed on the vomocytosis 
capability of Cryptococcus neoformans due to the possibility of maintaining carrier cell 
viability following this form of expulsion (Johnston et al., 2010). However, our initial 
experimentation elucidated that vomocytosis is a rare event (7 out of 100 000 cells) 
and responsible effectors are largely unidentified (Appendix 7). This could be 
attributed to the fact that C. neoformans does not seem to have  directly evolved with 
the purpose of evading the host immune system (Steenbergen et al., 2003) – at least 
in part because it seems dependent on host immunity for its ability to infect host cells, 
as poor infective capacity has been reported for C. neoformans in the absence of 
opsonisation (Johnston et al., 2013). Conversely, others have shown engulfment of L. 
monocytogenes to be independent of opsonisation (Pierce et al., 1996), a finding 
confirmed by our own results (Figure 4.9). Therefore, we shifted our attention to 
effectors already identified in other intracellular pathogens which are known to 
successfully evade host immunity. The keystone bacterium Porphyromonas gingivalis 
exhibits similar mechanisms of expulsion, with the advantage (at least in the current 
context) of almost exclusively disseminating in a non-lytic fashion (Takeuchi et al., 
2011). The high incidence of expulsion from host cells made this microbe a more 
desirable candidate compared to C. neoformans. Reports indicate 44% infection after 
24h incubation of uninfected cells with P. gingivalis containing cells (Yilmaz et al., 
2006), indicating the effectivity with which this bacterium can spread throughout the 
periodontium. These mechanisms are likely actin dependant and evade humoral 
immunity through direct cell-to-cell spread. However, the mechanisms of action 
responsible for this effective dissemination are even less well understood than those 
of C. neoformans. Nonetheless, from our review of the literature (as presented in 
Chapter 2), we identified a key similarity in these and other reports on microbial 
egress: the majority of literature consulted seems to describe a requirement for 
phagocytic engulfment with phagosomal manipulation by the microbe to maintain its 
own viability and even assist in its proliferation. This immune evasion technique is then 
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commonly followed by an actin polymerisation-dependent mechanism of egress from 
the host cell. Therefore, we shifted our focus to the better understood mechanisms of 
L. monocytogenes.  
5.1.1 Mechanisms of Listeria Effectors LLO and ActA 
The main effectors responsible for L. monocytogenes egress are LLO and ActA. 
Briefly, LLO create pores in the phagosomal membrane when under acidic pH 
conditions, to induce its escape into the cytosol (Alberti-Segui et al., 2007). Once in 
the cytosol,  activity of ActA is reported to induce actin polymerisation in the more 
physiological pH of the cytosol (Skoble et al., 2000). These effectors are not produced 
by other microbes; however, similar mechanisms of action are employed, and 
homologues do exist. Pore forming toxins other than LLO are produced by other 
bacteria and not only induce pore formation but also manipulate carrier cell ion 
concentration, manipulating infected cells in more subtle ways (Dal Peraro et al., 
2016). Furthermore, a similar actin polymerizing factor to ActA is produced in Shigella 
flexneri (IcsA) (Welch et al., 2013). ActA and IcsA are not homologues and induce 
polymerisation in distinct manners, but still achieve a similar outcome. For example, 
LLO negative mutants of L. monocytogenes are able to infect neighbouring cells via 
cell-to-cell spread but are unable to escape from these host cells. These microbes are 
harboured inside double membrane vesicles and are unable to disseminate due to 
absence of LLO pore formation (Gedde et al., 2000). Similarly, the absence of ActA in 
L. monocytogenes infection has been reported to render intracellular bacteria immotile 
and markedly non-infectious (Pillich et al., 2017). Thus, these effectors are of pivotal 
importance for L. monocytogenes dissemination and survival and use of these 
effectors in a synthetic microbe system would be advantageous. Purchased microbial 
effectors are expensive, and availability is limited. In addition, a substantial amount of 
effector would be needed for experimentation in a novel project like this. Given the risk 
involved in an ambitious endeavour such as proposed here, the high cost of effectors 
could not be justified. Practically, 50 µg of LLO costs ~$263 (Abcam) whereas we 
produced >50 mg/L for ~$145 ($0.145 per 50µg) In addition, we could only source 
ActA from MyBioSource at ~$775 for 50 µg and delivery to South Africa is limited. 
Furthermore, commercially available effectors are limited to those that are well-studied 
and commercially viable. This limits the combinations of effectors that can be used, 
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especially if working with novel effectors. In order to overcome these limitations 
heterologous expression was utilized. 
5.2. Effector Synthesis 
Previously, LLO has been purified from L. monocytogenes directly - however, these 
methods resulted in low yield and were relatively time consuming (Traub et al., 1995). 
Other authors turned to purification of LLO from E. coli to increase yields while lowering 
production time (Churchill et al., 2005). Methods for purification of ActA have also been 
established (Kocks et al., 1993; Welch et al., 1998; Noireaux et al., 2000; Skoble et 
al., 2000). These purified proteins had appropriate activity by either erythrocyte lysis 
(LLO) or actin polymerisation (ActA). Most notably, recombinant LLO has been used 
for the effective delivery of several compounds to the cytosol of cells (Mandal et al., 
2002; Provoda et al., 2003; Stier et al., 2005). However, yields needed to be further 
improved for our application.  
Fusion of proteins to GFP for heterologous expression have been previously reported. 
This fusion helps in soluble expression of functional proteins and has recently been 
reported by our group for the expression of lanthipeptides (van Staden et al., 2019) 
(used in Chapter 3). Similar methods have also been employed for the expression of 
LLO (Kwiatkowska et al., 2017) and ActA (Noireaux et al., 2000). However, these 
studies did not focus on increasing protein yields or using GFP fluorescence during 
purification. Using this method, we isolated sufficient protein for experimentation in our 
synthetic microbe system, while maintaining appropriate haemolytic and actin 
polymerizing activity for synthesised LLO and ActA, respectively. Of note is the 
heterologous GFP-linked expression method used for LLO resulting in significantly 
greater yields (> 50 mg/L) when compared to previously reported yields of 3.5 – 8 
mg/L (Churchill et al., 2005). In terms of haemolytic capacity of LLO in particular, a 
noteworthy additional finding was that GFP-fused LLO showed appropriate pH 
dependant haemolytic capacity of similar potency when compared to unbound LLO, 
suggesting that GFP-fusion does not affect activity of LLO. This is particularly 
interesting as GFP fusion could be used in future studies to easily determine the 
intracellular location of exogenous LLO, while maintaining the pH-dependent pore 
forming capacity of this toxin.  
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The pH-dependant nature of LLO pore formation is advantageous in a synthetic 
microbe system as this opens possible manipulation methods. For example, the pore 
forming capacity can be controlled for by inducing phagosome maturation arrest, 
leading to prolonged phagosome alkalinity. Thus, allowing a window period during 
which the carrier cells are able to reach the target location for delivery. Upon reaching 
the site, transient maturation arrest would be lost, and acidification induced LLO pore 
formation occurs to release the therapeutic cargo. In this regard, we have conducted 
a pilot study to determine the temporal limit of phagosome maturation arrest at 
between 2-3 hours post exposure to a phagosome maturation arrest inducing cocktail 
(Appendix 8). 
The use of a dual tagged system has previously been used for the expression of ActA 
(Noireaux et al., 2000). In this study the authors used an N-terminal GST-tag and a C-
terminal His-tag, without removal of the N-terminal tag after purification. Using the 
method described in our study we were able to visualize expression (through GFP 
fluorescence) during the different purification steps as well as the degradation that 
takes place. Furthermore, by removing the N-terminal GFP-tag our construct more 
closely resembles that of native ActA found on the membrane of L. monocytogenes.  
5.3. Validation of In Vitro Effector Activity 
Following confirmation of appropriate activity in solution, these effectors were coated 
onto beads to determine their capacity to induce expulsion from carrier cells. These 
beads represented the cargo of interest. Carboxylate modified beads were used as 
previous reports indicate that ActA does not bind to hydrophobic latex (Footer et al., 
2008). In addition, 0.2 µm beads were chosen due to previous reports of directional 
actin polymerisation-induced movement following coating of 0.5 µm carboxylate 
modified beads with ActA (Cemeron et al., 1999). Furthermore, current drug delivery 
systems utilise cargo of ~ 0.2 µm in size (Kleynhans et al., 2019), similar to the size of 
our cargo. 
These findings indicated a good likelihood for these LLOActABeads to induce 
expulsion from carrier cells. Initial evaluations were conducted via confocal 
microscopy and time lapse imaging to pinpoint expulsion. However, due to the lower 
optical range of 0.2 µm on the confocal microscope and the abundance of beads 
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present in samples, an unbiased evaluation could not be guaranteed. Larger beads 
conjugated with the required fluorophore could also not be sourced, thus 0.2 µm beads 
had to be used. The inability to differentiate a released bead from beads that have not 
yet been taken up was also problematic. Furthermore, this process was extremely time 
consuming and costly with a relatively low experimental success rate. Thus, we opted 
for high throughput assessment where the entire sample could be quantitatively 
analysed to determine cellular bead content. We acknowledge the importance of time 
lapse microscopy as definitive visual proof. However, our option of imaging flow 
cytometry is superior to time lapse confocal microscopy in terms of generation of 
quantitative data. Our approach allowed for greater statistical power and takes the 
entire sample into consideration, thereby generating an unbiased quantitative data set.  
High throughput analysis showed accumulation of intracellular beads under control 
conditions with a significantly lower accumulation during effector exposure. This 
phenomenon indicates that effector exposure induced either expulsion of intracellular 
beads or reduced the initial uptake of beads. The percentage of cells containing any 
number of beads were counted during each time point and treatment condition. This 
number indicates the percentage of cells that were able to phagocytose the cargo. A 
reduction in this percentage indicates that less cells were able to phagocytose the 
beads, and this would be reflected in the number of beads per cell. Here we found that 
the percentage of cells containing any number of beads remained the same for time 
and treatment (Figure 4.15). The number of beads per cell in the earliest 15 min time 
point of Figure 4.14 is also surprisingly similar for LLOActABeads and SerumBeads, 
indicating a similar propensity for engulfment under both conditions. Thus, 
LLOActABeads exposure induced expulsion of these beads over time and reduction 
thereof cannot be attributed to weaker bead engulfment. This is a novel discovery as 
no previous reports have shown intended and induced expulsion of cargo from carrier 
cells, using microbial effectors, in the absence of infection. 
Macrophages exposed to LLOActABeads presented marked actin polymerisation as 
well as clear membranous actin spikes. This is in accordance with reports of actin 
propelled membrane protrusions that are taken up by adjacent cells during L. 
monocytogenes dissemination (Pizarro-Cerda et al., 2012). Listeriolysin-O damages 
the plasma membrane of these protrusions resulting in surface presentation of the 
inner membrane leaflet lipid, phosphatidylserine (PS). These PS+ protrusions are 
Stellenbosch University https://scholar.sun.ac.za




recognised by the T cell immunoglobulin and mucin-domain containing protein 4 (TIM-
4) on macrophages, which subsequently mediates the uptake of PS+ protrusions 
(Czuczman et al., 2014). Expelled bacteria may also be packed into PS+ vesicles, 
formed as a result of Ca2+ dependent membrane repair and scission of the initial PS+ 
protrusion (Czuczman et al., 2014). Both PS+ vesicles and protrusions are similarly 
taken up by neighbouring cells via TIM-4. This method of cell-to-cell spread was 
however not observed in the current study. One reason for this could be that cells were 
located to sparsely relative to each other in this in vitro model, so that reuptake could 
not readily happen. An alternative reason could be that the actin polarisation may have 
interfered with PS vesicle formation, so that expelled cargo was not associated with 
PS, and thus not readily taken up via TIM-4. There is the possibility that residual LLO 
itself could serve as opsonin for reuptake into neighbouring cells, but if this was to 
occur, one would not expect to see the clear decrease in the number of intracellular 
beads in the LLOActABeads group. Thus, although this remains to be definitively 
confirmed in an in vivo model, this does not take away from our data which indicates 
successful bead expulsion. 
For the sake of comprehensiveness, potential alternative interpretations for current 
data should be considered. The fact that each cell could not be labelled and followed 
individually to visually exact bead uptake and expulsion mechanisms, raises the 
possibility that beads could have been expelled via other mechanisms than that 
suggested here. For example, it could be argued that beads were able to passively 
move through the cell membrane, as has been shown for nanoparticles in the past 
(Tammam et al., 2017). However, in the current scenario, it is unlikely that passive 
movement of beads would have resulted in the average number of beads per cell 
being significantly different between the two treatment conditions, as was the case 
here. Seeing as this average was statistically different, it can only be argued that the 
presence of LLOActABeads indeed influenced the cells to induce significantly “loss” 
of beads.  
Furthermore, our data indicated that LLO itself served as an opsonin to upregulate 
bead uptake (Appendix 6). Thus, if no bead expulsion had occurred, one would 
expect a larger percentage of phagocytically active cells and a larger number of beads 
per cell in the LLOActABeads group when compared to the control – the opposite of 
what if reflected in current data  
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It is also necessary to consider that beads may have been expelled via mechanisms 
other than the currently known mechanisms of LLO and ActA. Firstly, it is theoretically 
possible that these effectors induced homeostatic recycling of cargo from 
macrophages, in a manner similar to nutrient digestion and excretion. To determine 
this, one would need to stain for secretory granules and their markers. Nonetheless, 
this is still unlikely as our initial findings indicated a significant influence of ActA on 
actin, evidenced by actin membrane spikes as well as actin ‘clouds’. Furthermore, 
appropriate pH-dependent activity of LLO was also observed. Secondly, considering 
that secretory granules alkalinise during exocytosis (Li, 2017), it could also be possible 
that the effectors induced cellular exocytosis in a manner independent of LLO activity. 
To this end, the phagosome could have alkalinised in preparation to expel its cargo 
into the extracellular matrix, thus, leading to inactivity of LLO in this alkaline 
environment but still ultimately ending in expulsion. This could be addressed in a 
number of ways that will be discussed in the future recommendations section. This 
being said, reports have indicated some effects of LLO on host cell genetic material 
(Hernández-Flores et al., 2015). It could therefore be possible that modulation of gene 
expression induced expulsion from the cell. This option remains to be revisited as 
more information becomes available on the intracellular interactions of LLO, to fully 
explore this possibility. However, none of the aforementioned alternative 
interpretations provides sufficient arguments against our finding that LLOActABeads 
treatment induced some mechanism by which ingested beads exited from the cells 
without damaging them. 
On a technical note, actin spikes observed during LLOActABeads exposure may be 
misinterpreted as pseudopodia. However, there is a marked difference in rigidity 
between the two extruding structures: pseudopodia present as more curved structures 
(See Figure 4.10 and Figure 5.1 for examples) - as expected when considering that 
pseudopodia need to encircle the material of interest in order to engulf it – whereas 
actin spikes present as linear, rigid structures. These actin spikes observed in the 
current study are likely the fluorescent remnants of a bead that has been expelled 
through the membrane via ActA induced actin polymerisation originating from within 
the cytosol. Thus, the expression of high numbers of these spikes in the 
LLOActABeads group confirms that beads were continually being expelled. In addition, 
it is important to note morphological differences between primary isolated 
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monocyte/macrophages and established cell lines such as J774 cells. These cells 
could present marked differences during phagocytosis or expulsion of cargo. One 
example from our group could be mentioned in this regard, where treatment of primary 
macrophages with phagosome maturation arresting agents did not significantly affect 
cell viability, however, treatment of J774 cells with these agents resulted in significant 
viable cell loss (data not shown).  
Furthermore, although LLO is able to perforate membranes, carrier macrophages did 
not exhibit apparent cellular perturbations evidenced by intact cell nuclei. In addition, 
other authors have reported internalisation of LLO coated beads as well as entry of 
noninvasive Listeria innocua into cells, indicating that these effectors are likely more 
opsonising in nature (Vadia et al., 2011). Therefore, we propose that the number of 
beads per cell – and by extension the percentage of phagocytically active cells – would 
be elevated under conditions of LLOActABeads exposure rather than inhibited.   
 
Figure 5.1: Differentiation between pseudopodia and actin spikes. Human macrophage extending 
pseudopodia toward 4 µm polystyrene beads coated with serum. Another macrophage containing 7 
polystyrene beads is also shown. 
 
Together, this provides evidence that the correct combination of synthesised effectors 
can be used to effectively mimic microbial effects on cellular processes, such as matter 
expulsion from phagosomes. Thus, this is novel evidence of how microbial processes 
may be harnessed for therapeutic benefit. 
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Chapter 6: Conclusion and Future Recommendations 
The findings presented here illustrate a novel prototype drug delivery system – the 
synthetic microbe – by which to achieve drug expulsion from human macrophage 
shuttles. A particularly novel approach is the use of harnessing microbial effectors to 
facilitate expulsion, in the absence of infection or micro-organisms, which largely 
negates concerns about risk to the patient recipient. Current data illustrate that the 
microbial effectors, LLO and ActA, can be employed to achieve their native affect 
without adverse outcomes to host carrier cells. This could initiate a paradigm shifting 
research area into the treatment of a plethora of diseases, which are currently 
hampered by limitations such as poor blood supply or high toxicity of pharmaceuticals.  
The exact mechanism with which LLO and ActA induce expulsion also need to be 
addressed by utilising time lapse microscopy. This was not a focus point during the 
current study as the possibility of expulsion needed to be indicated before one could 
endeavour into the exact mechanisms by which this is achieved and determine if the 
above stated mechanisms are at all true. The phagosome of macrophages would 
firstly need to be labelled with Rab5, Rab7 and LAMP1 to determine normal 
phagosome maturation. This would support the acidic activation of LLO and determine 
of the cargo exits the phagosome before expulsion or not. Additionally, to more 
precisely determine this, one could add the acidification marker pHrodo (Thermo 
Fisher) to cells. This marker emits at wavelength 533nm once inside an acidic 
environment and has no excitation/emission at above pH 6 (Visser et al., 2018). Thus, 
it is able to determine if the phagosomes acidify prior to expulsion – supporting activity 
of LLO – or if the phagosomes alkalinise before expulsion – supporting the induction 
of exocytosis in a more homeostatic manner. Furthermore, one could conduct 
transcriptomics to determine a genetic adaptation of host cells due to LLO exposure, 
as previous reports have indicated transcriptional modification (Hamon et al., 2007, 
2012). 
Additional follow-on experiments of the current study include testing of different 
effector concentrations coated onto beads. Future studies could include lower and 
higher concentrations of LLO and ActA to determine a possible dose response in bead 
expulsion over time. This would prevent, possible, over exposure of the patient to LLO 
and/or ActA and limit costs associated with protein synthesis.    
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The processing time required for isolation, culture and manipulation of cells in the 
current project, is a limitation in regard to acute treatment regimes. In an attempt to 
circumvent extended culture periods, we assessed the migratory capacity of 
phagosome maturation arrested monocytes. Unfortunately, this pilot study showed no 
migration of manipulated monocytes. However, these monocytes were able to 
phagocytose cargo. Thus, it is possible that cargo expulsion could also be induced 
within these monocytes, if the need for delaying expulsion is not necessary, making 
this prototype more applicable to acute as well as chronic diseases.  
Together with our previously described prototype – a macrophage drug shuttle – we 
believe that we have now arrived at a complete system for drug delivery which is ready 
for in vivo testing. Aspects which can only be accurately assessed and optimised in 
an in vivo model, include: a) the rate and extent of bead expulsion from host 
macrophages, b) identification of additional components to incorporate into the 
synthetic microbe with which to modulate these aspects for more control over the 
expulsion process, c) confirming the accuracy with which drug delivery occurs focally 
at the intended delivery site only and d) the effect of carrier macrophages on 
inflammation and other cellular and tissue recovery processes after drug delivery.  
Additional aspects regarding development of a polymer coating evaluated through in 
vitro investigation include a) optimisation of cargo coating and effector ratios, b) 
investigation into additional or more effective effectors to incorporate into the multi-
layered polymer coating and c) controlling the accuracy of drug delivery by adapting 
this polymer coating. 
Transient phagosome maturation arrest would need to be utilised to lengthen the 
period of cargo harbouring before effectors are activated and expulsion induced. 
Preliminary findings have been promising to indicate a prolonged period of cargo 
retention before expulsion is initiated. This would allow time for carrier macrophages 
to reach the intended area. The better this resolution of phagosome maturation arrest 
can be controlled, the more likely a burst release of cargo can be achieved. This would 
alleviate previous limitations in conventional drug delivery by administering an 
adequate dose to the target area. In addition, this would prevent excessive host drug 
exposure. Thus, a smaller amount of drug, at a higher concentration can be 
administered to the target area only. 
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The use of a multi-layered nanoparticle coating may also be necessary to facilitate 
more controlled delivery. An outermost pH sensitive layer may lengthen the period of 
cargo harbouring, with incorporation of escape inducing agents (i.e. LLO and ActA) 
into a middle layer (Chapter 2). This will allow time for transient phagosome 
maturation arrest to expire, subsequently lowering phagosomal pH and degrading the 
outermost layer before reaching and releasing this effector treated layer. Furthermore, 
an additional inner most coating could be included to protect the cargo itself from 
phagosomal pH drop and degradation. In addition, this layer could ensure cargo is 
kept intact. This innermost protective layer could also be designed so that it may be 
externally broken down by e.g. ultrasound administration. This would prevent host 
exposure to drugs deposited at unwanted locations. The need for controlled delivery 
can only be evaluated once an in vivo trial has been executed. Similarly, we envisage 
that the type of polymer and/or external triggers will be dictated by the specific 
application for which the synthetic microbe is required. 
In terms of specificity of delivery to required sites, deposition of cargo at unwanted 
locations is unlikely, as macrophages infiltrate into damaged/infected areas during the 
inflammatory process – which is expected to prevail at sites of infection. However, this 
potential risk cannot be ignored, and in vivo evaluation is required to confirm specificity 
of focal delivery. For this reason, patients receiving this treatment would likely need to 
be evaluated beforehand to ensure that no additional sites of inflammation exist. This 
is not an uncommon procedure as patients are readily kept for screening before 
therapeutic intervention. Practically, drug and cell location within the host could still be 
evaluated in real time, during or post treatment. To this end, GFP bound LLO was 
shown to have similar activity to unbound LLO. Thus, pre-clinical in vivo (likely 
zebrafish) testing and optimisation of drug deposition locations should be conducted. 
Furthermore, cell labels such as CellTracker Violet (Thermo Fisher) can be used to 
determine locations of carrier cells during zebrafish in vivo testing. 
Finally, migration of carrier cells to target locations could potentially alleviate 
inflammation due to macrophage phenotype plasticity. Once the delivered drug had 
exerted its antimicrobial effect, the extracellular milieu will change. We hypothesise 
that this may result the carrier M1 macrophages to undergo a phenotype shift toward 
M2 anti-inflammatory macrophages. These macrophages would be able to contribute 
to resolution of inflammation/infection. 
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Taken together, we believe that the findings reported here present a prototype which 
– after rigorous in vivo evaluation and optimisation – has a high likelihood for 
translation into clinical practice. 
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Appendix 1: Basic macrophage biology and the Molecular Basis of 
Phagocytosis 
 
The M1 macrophage phenotype is the only phenotype to have been shown to migrate 
through endothelial barriers (Arnold et al., 2007 b; Chazaud et al., 2009). This 
phenotype is also honed toward particle engulfment and digestion, and is the main 
phenotype to which inflammatory monocytes differentiate (Imhof et al., 2004; Freeman 
et al., 2014). Monocytes have a relatively short lifespan in circulation (10-20 hours) 
(Guyton et al., 2011). Extravasation of monocytes is needed to induce differentiation 
into resident tissue macrophages. This process ensures a significant increase in 
lifespan through the protective and nutrient- and chemokine-rich extra-circulatory 
environment that augment cell survival. The M2 phenotype is more closely associated 
with resolution of inflammation (Abbas et al., 2014) and macrophages do present with 
some phenotype plasticity (Mosser et al., 2008). Thus, it is an additional future aspect 
of this project to determine if delivered M1 macrophages are able to shift toward the 
M2 phenotype after deposition of cargo. This would have to be tested in vivo.  
 
Recognition 
Macrophages recognise matter as foreign via binding to different pattern recognition 
receptors (PRRs) found on immune cells of both the innate and adaptive branch 
(Anderson et al., 2012). PRRs differentiate between molecules released from dying 
self-cells and foreign material through binding to damage-associated molecular 
patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs), respectively 
(Abbas et al., 2014). Self-cells undergoing necrosis release formylated peptides such 
as N-formylmethionine from damaged mitochondria (Zhang et al., 2010). These self-
originating DAMPs can bind to formyl peptide receptors on monocytic cells, initiating 
chemotaxis and eventualy phagocytosis (Bardoel et al., 2011). Recognition of PAMPs 
is oriented toward many PRR subtypes, such as NOD-like receptors (NLRs) 
(recognise DAMPs as well), RIG-like receptors (RLRs) and Toll-like receptors (TLRs). 
NLRs are mainly associated with sterile inflammation like gout via NLRP3 associated 
inflammasome formation (Misawa et al., 2013). The membrane bound TLRs bind 
bacterial hallmark molecules. The TLR5 subtype typically binds to flagella, while TLR2 
and TLR4 binds bacterial cell wall components like peptidoglycan and 
lipopolysaccharide (LPS), respectively (Abbas et al., 2014).  
IgG receptors are more closely associated with phagocytosis. IgG antibodies attach 
to microbes to opsonise them. This opsonisation facilitates phagocytosis of material. 
Macrophages recognise the constant γ heavy chain in Fc regions of IgG antibodies 
with Fcγ receptors (CD64) on their cell surface. Recognition induces FcγR clustering 
and subsequent actin polymerization and engulfment through pseudopod extension 
(Swanson et al., 2004). Pseudopodia formation and actin polymerization is dependent 
on PI3k recruitment for production of phosphatidylinositides. FcγR mediated 
phagocytosis is the main form of phagocytosis simulated in experimental phagocytosis 
models, because engulfment does not require stimulation by other cells types like T 









Pseudopodia and Encapsulation 
Phagocytosis is initiated by extension of pseudopodia. Internalisation and nascent 
phagosome formation are completed within 5 min (Visser & Smith, unpublished data). 
Macrophages are extremely ambitious in their phagocytic ability and are able to engulf 
particles that are closely comparable with their own size (Huynh et al., 2007). This 
leads to the question of where the extra membrane is produced. This can be 
addressed by looking at the type III PI3k.   
The type III PI3ks consists of one catalytic subunit in humans, hVPS34. Type III PI3ks 
phosphorylate phosphatidylinositol (PI) to PI3P on endosomes and autophagosomal 
structures (Backer, 2008). Formation of PI3P is accompanied by the closure of the 
phagocytic cup and subsequent disappearance of PI(4,5)P2 (Botelho et al., 2000) that 
lead to and are essential for maturation of newly formed phagosomes (Vieira et al., 
2001). Thus, PI3P function is centred more around phagosomal/endosomal 
maturation than as a source of extra membrane during engulfment.  
 
Nascent Phagosomal Stage 
This stage can be distinguished from engulfment by phagocytic cup closure behind 
the engulfed material of interest. Pseudopod closure is dependent on type I PI3k, PIP3 
and PI(4,5)P2. Inhibition of PI3k with, LY294002, prevented antibody opsonized 
particle engulfment as a result of unsuccessful pseudopod closure (Beemiller et al., 
2006).  
The successfully engulfed material is encapsulated into a nascent phagosome 
expressing Rab5 (Fairn et al., 2012). Rabex-5 is requited an activates Rab5 (Horiuchi 
et al., 1997). Rab5 then recruits endosomal early antigen 1 (EEA1) (Scott et al., 2002) 
and the type III PI3k, hVPS34, (Kinchen et al., 2008) to the phagosome. PI3P is 
generated by hVPS34 on the cytosolic side of the nascent phagosome and serves as 
a docking station for other maturation effectors. EEA1 can then dock onto PI3P and 
ensures EEA1-mediated tethering and fusion of phagosomes with late endosomes for 
further maturation (Vieira et al., 2002). EEA1 thus plays a central role in phagosome 
maturation.  
 
Late Phagosomal Stage 
GTPase-activating protein (GAP) mediates Rab5 inactivation and dissociation, 
marking the late phagosomal stage (Fairn et al., 2012). This is accompanied by Rab7 
recruitment, late endosome fusion, expression of markers like mannose-6-phosphate 
receptor (MPR), lysobisphosphatidic acid (Fratti et al., 2001) and LAMP (Desjardins, 
1995). During this stage, PI3P is incorporated and degraded inside the phagosome 
(Gillooly et al., 2000). Elimination of PI3P is likely necessary for removal of nascent 
phagosomal markers, dependent on PI3P expression, such as EEA1. The late 
phagosomal stage is initiated, in vitro, at about 10-30 min after formation of the nascent 
phagosome (Fratti et al., 2001). This  coincides with PI3P disappearance at 10 min 
after its formation (Vieira et al., 2001).  
The expression of Rab7 on both late endosomes and late phagosomes allows Rab7 
to regulate membrane trafficking between nascent phagosomes, late phagosomes 
and lysosomes (Press et al., 1998). Fusion between nascent phagosomes and late 
endosomes could allow for close proximity of Rab7 and PI3P that facilitates SNX 
retromer functioning (Cullen et al., 2011). Thus, SNX retromers likely recycle cargo 
between nascent phagosomes and late phagosomes. Rab7 accelerates maturation to 
the phagolysosome biogenesis stage via the action of Rab7-interacting-lysosomal-
protein (RILP) (Harrison et al., 2003). RILP and oxysterol-binding protein related-
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protein 1 (ORP1L) together link phagosomes to dynein (Johansson et al., 2007), for 
centripetal movement of late phagosomes along microtubules toward lysosomes for 
fusion (Harrison et al., 2003). Dynein mediated lysosome fusion is likely dependent on 
Rab7 and the HOPS complex (Akbar et al., 2011). HOPS acts as a tethering protein, 
keeping phagosomes and lysosomes in close proximity to each other, similar to the 
function of EEA1 (Hickey et al., 2010).  
 
Phagolysosome Biogenesis Stage 
Lysosomal fusion with phagosomes is the final stage in maturation, referred to as 
phagolysosome biogenesis (Seto et al., 2011). This stage is achieved around 1 h after 
formation of nascent phagosomes, under in vitro conditions (Jahraus et al., 1998). 
SNARE proteins mediate fusion (syntaxin 7, syntaxin 8, VAMP7 and VAMP8) (Becken 
et al., 2010) and provide phagolysosomes with proteases (e.g. cathepsin D), reactive 
nitrogen species (RNS) and reactive oxygen species (ROS) with which to neutralize 
ingested particles. Fusion also elevates LAMP expression and facilitates an acidic 
phagosomal lumen (Jahraus et al., 1994). 
Phagolysosomal degradation of protein is hugely dependant on proteases such as 
cathepsin D. Delivery of this protease is controlled by the trans-Golgi network-localised 
Rabs (22b, 32, 34,38 and 43) (Ng et al., 2007). Blockage of cathepsin D delivery 
resulted in phagosome maturation arrest. The ER-localized Rab20, was reported to 
co-localize with V-ATPases on phagosomes, suggesting its involvement during 
phagosome acidification (Curtis et al., 2005).  
It seems that phagocytosis has evolved from endocytic nutrient processing to a 
specialized self-defence mechanism conserved uniquely to professional phagocytes. 
This phenomenon can, however, still be manipulated and applied to therapy, as the 








Appendix 2:  ActA Expression Optimisation 
Expression of ActA proved difficult as degradation was evident when separated via 
SDS-PAGE. Initial experiments using GFP-ActA resulted in significant degradation 
even at different incubation times after expression (Figure 1). Cleavage of GFP-ActA 
with WELQut protease resulted in dropouts corresponding to ActA and GFP, but with 
significant degradation (Figure 2). In order to better visualize the degradation, a 
second fluorescent marker (mCherry) was incorporated at the C-terminal of GFP-ActA. 
Before and after cleavage of GFP-ActA-mCherry with WELQuet protease and 
separation using SDS-PAGE, clear degradation patterns could be observed (Figure 
3). From the fluorescent image of the SDS-PAGE gel multiple red fluorescent bands 
could be observed, which corresponds to different ActA-mCherry products (intact 
ActA-mCherry and degradation products). The degradation patterns do not give much 
insight into where the degradation takes place, due to the aberrant migration of ActA 
in SDS-PAGE gels. It is possible that some E. coli proteases that are co-purified with 
various ActA constructs cause the degradation. Therefore, it was ultimately decided 
to utilize a dual purification method as to reduce the capture of degradation products 
and possible proteases that are co-purified (as the two affinity purification methods are 
fundamentally different).  
 
Figure 1: SDS-PAGE of GFP-ActA expressed for different times at 26°C. Left: Stained gel, Right: 
Fluorescent image of GFP-ActA and degradation products. L: Ladder (NEB ladder #P7712), 1-4: 2, 4, 
6, 18 hours expression, respectively. Black arrow indicates GFP-ActA. Degradation products are 
outlined in red. 
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Figure 2: SDS-PAGE GFP-ActA cleavage. Left: Stained gel, Right: Fluorescent image of GFP-ActA 
and GFP. L: Ladder (NEB ladder #P7712), 1: Uncut GFP-ActA, 2: GFP-ActA cut with WELQut protease. 




Figure 3: SDS-PAGE GFP-ActA-mCherry cleavage. Left: Stained gel, Right: Fluorescent image. L: 
Ladder (NEB ladder #P7712), 1: Uncut GFP-ActA-mCherry, 2: ActA-mCherry cut with WELQut 
protease. A: GFP-ActA-mCherry, B: ActA-mCherry, C: truncated ActA-mCherry, D: GFP. 
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Appendix 3: Preparation of Macrophages for Imaging Flow 
Cytometry 
A pilot study was launched to determine the most effective method of lifting 
macrophages from culture surfaces, while maintaining labelled fluorescent markers. 
Live cell imaging has the advantage to record cells in an unhindered state, but, in the 
case of imaging flow cytometry cells need to be lifted from culture surfaces without 
damaging membranes or confounding experimental outcomes. Primary macrophages 
are also notoriously hard to lift from surfaces in a viable state. Thus, different methods 
of fixing cells prior to lifting and fixing after lifting was tested (Figure 4). In Figure 4 
the methods are ranked according to effectiveness with optimal combinations for 
viable cell yield ranked highest on the y-axis and optimal combinations for membrane 
marker retention ranked highest on the x-axis. Generally, lifting cells prior to fixing with 
PBS containing 1mM ethylenediaminetetraacetic acid (EDTA) resulted in higher cell 
viability (determined via Hoechst staining), compared to commercially available 
Accutase lifting. However, PBS-EDTA treatment led to incomplete retention of the 
fluorescent membrane marker (CellMask Orange). This is particularly interesting when 
considering that complete (100% of cells recorded) membrane marker retention was 
recorded with 23˚C Accutase treatment. Thus, it is important to compare different cell 
detachment methods, especially during flow cytometric analysis, as the use of PBS-
EDTA could have confounded results obtained from further experimentation. To this 













Figure 4: Expression of viable cell yield over membrane marker retention. Values expressed as 
absolute cell yield over percentage of membrane positive cells. Plotted according to (x;y) co-ordinates. 
37˚C PBS-EDTA Fix (23.46%;11426), 4˚C PBS-EDTA Fix (0.0950%;5438), 23˚C Accutase Fix 
(100%;4868), 37˚C PBS Fix (0.1952%;3360), 4˚C PBS Fix (0.2364%;3151), Fix 4˚C PBS 
(0.0061%;2069), Fix 4˚C PBS-EDTA (0.0127%;1933), Fix 4˚C HBSS (0.0018%;1780), 4˚C HBSS Fix 
(0.0003%;1614), 4˚C Accutase Fix (2.034%;100). A threshold for marker retention is indicated in grey. 
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Appendix 4: GFP-LLO Migration in Gels 
Separation of GFP-LLO using SDS-PAGE resulted in a band corresponding to a size 
slightly lower than that predicted for GFP-LLO (~ 85kDa). In order to visualize GFP 
fluorescence in SDS-PAGE gels samples are not boiled, which may result in faster 
migration through the gel. In order to confirm this, GFP-LLO was incubated with SDS-
PAGE sampling buffer at 37°C for 30 min or boiled for 5 min. Gels were 
electrophoresed as described in Chapter 3. From SDS-PAGE gels it is evident that 
treatment of the sample before loading does indeed influence its migration through the 
gel (Figure 5). Boiling the samples resulted in a single band corresponding to the 
correct size of GFP-LLO (Figure 5 B). Cleaved and purified LLO does not suffer the 
same discrepancy with regards to migration through the gel. 
 
Figure 5: SDS-PAGE GFP-LLO and LLO treated at 37°C (A) or 100°C (B) before SDS-PAGE 
separation. Left: Stained gel, Right: Fluorescent image of GFP-LLO (37˚C). L: Ladder (NEB ladder 
#P7712), 1: GFP-LLO eluted from IMAC column, 2: GFP and WELQut eluted from column after GFP-
LLO digestion, 3: Flow through from IMAC column containing LLO. GFP-LLO and LLO indicated with 
green and black arrows, respectively. GFP and WELQut protease indicated with green and red stars, 
respectively. C) Fluorescent image of Gel depicted in figure (A).  
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Appendix 5: Phalloidin Actin Staining in Live Cells 
The possibility of labelling live cells with the phalloidin actin stain was determined 
(Figure 6). The stain was taken up by live primary isolated macrophages, however, it 
remained within intracellular phagosomes throughout the experimental period. Thus, 
only fixed cells were labelled with the actin stain. 
 
Figure 6: Actin phalloidin stain taken up by live cells. The actin phalloidin stain remained inside 
phagosomes when taken up by primary macrophages.  
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Appendix 6: Opsonising Effect of LLO 
The capacity of macrophages to engulf beads coated with microbial effectors was 
determined by coating 4 µm carboxylate modified polystyrene beads with LLO. 
Satisfactory engulfment was observed 30 min post introduction of LLO coated beads 
(Figure 7). Engulfment increased until all observed cells contained beads. Previously 
fluorescent antibody coated beads needed to be exposed to serum in order to 
opsonise the beads and induce engulfment. These findings indicate that LLO is 
opsonic in nature. Thus, exposure of macrophages to LLOActABeads would more 
readily result in a normal (or upregulated) engulfment rate, than inhibition thereof.  
 
Figure 7: Engulfment of LLO coated beads. Primary macrophages readily engulfed LLO coated 








Appendix 7: Incidence of Cryptococcus neoformans Vomocytosis 
A pilot study was conducted to determine the incidence of vomocytosis. J774 
macrophages were infected with C. neoformans and vomocytosis only occurred in ~7 
out of 100 000 infected cells. Representative images of vomocytosis are given in 
Figure 8.  Due to the very low occurrence of vomocytosis in this micro-organism, 
attention was shifted toward the more effective egress inducing pathogen, Listeria 
monocytogenes. 
 
Figure 8: Incidence of Cryptococcus neoformans vomocytosis. Infected J774 macrophages 








Appendix 8: Delaying Cargo Expulsion 
Cargo delivery with the synthetic microbe model needs to be time dependant as carrier 
cells need to be able to reach target destinations before expulsion of drugs or cargo. 
Thus, carrier macrophages were treated with phagosome maturation arresting agents 
to prevent acidification of phagosomes that in turn prevents activation of LLO, 
subsequently delaying the effect of ActA to induce cargo expulsion. The percentage 
of non-effector exposed cells carrying degraded cargo is plotted over time (Figure 9). 
A marginal difference in the number of cells with degraded cargo can be seen during 
the 2-hour time point. This degradation process is increased around 3 hours where 
after it reaches control conditions. This curve indicates that phagosome maturation 
arrest is maintained for around 2 hours post treatment with arrest inducing agents.  
 
Figure 9: Degradation of Cargo. Values expressed averages with errors bars indicating SEM. 
The temporal limit of phagosome maturation arrest during LLOActABeads exposure 
was determined (Figure 10). Preliminary results indicate a marked reduction in the 
arrested period to about less than 30 min. Indicated by a steep increase in the number 
of beads per cell (Figure 10) until around 30 min, after which the number of beads per 
cell plateau out. This could be attributed to bead expulsion being induces from the 30 
min time point or to a limit in bead uptake being reached at 30 min. However, additional 
data would need to be collected to adequately determine this. 
 









































Figure 10: Expulsion efficiency during phagosome maturation arrest. Graph indicate the number 
of average beads per cell during macrophage phagosome maturation arrest. Values expressed 
averages with errors bars indicating SEM. 
 
Table 1.1: Examples of drug delivery systems: Reticuloendothelial System (RES), Gastrointestinal Tract (GIT). 
1: (Langer et al., 1976; Cohen et al., 1991; Kim et al., 1999; Ding et al., 2006) 2: (Sugahara et al., 2010; Nance et 
al., 2012; Bertrand et al., 2014; Zhao et al., 2014; Hoshyar et al., 2016) 3: (Ghalanbor et al., 2010) 4: (Pasut et 
al., 2012) 5: (Edwards, 1997) 6: (Abla et al., 2005; Chen et al., 2006; Alkilani et al., 2015) 7: (Morishita et al., 
2006).  
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